Abercrombie & Fitch (ANF) 10-Q 8 Sep 21 2021 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Jul. 31, 2021	Sep. 03, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jul. 31, 2021
Document Transition Report	false
Entity File Number	001-12107
Entity Registrant Name	Abercrombie & Fitch Co.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	31-1469076
Entity Address, Address Line One	6301 Fitch Path,
Entity Address, City or Town	New Albany,
Entity Address, State or Province	OH
Entity Address, Postal Zip Code	43054
City Area Code	(614)
Local Phone Number	283-6500
Title of 12(b) Security	Class A Common Stock, $0.01 Par Value
Trading Symbol	ANF
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		59,082,477
Entity Central Index Key	0001018840
Current Fiscal Year End Date	--01-29
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q2
Amendment Flag	false

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended			6 Months Ended
	Jul. 31, 2021	Aug. 01, 2020		Jul. 31, 2021	Aug. 01, 2020
Document Period End Date				Jul. 31, 2021
Net sales	$ 864,850	$ 698,328		$ 1,646,255	$ 1,183,687
Cost of sales, exclusive of depreciation and amortization	301,365	274,720		587,636	495,934
Gross profit	563,485	423,608		1,058,619	687,753
Stores and distribution expense	325,935	310,370		642,543	632,494
Marketing, general and administrative expense	123,913	97,252		244,860	205,509
Flagship store exit benefits	(88)	(3,884)		(1,188)	(4,427)
Asset impairment	786	8,083		3,450	51,011
Other operating income, net	(1,848)	(2,356)		(3,266)	(1,850)
Operating income (loss)	114,787	14,143		172,220	(194,984)
Interest expense, net	11,275	7,098		19,881	10,469
Income (loss) before income taxes	103,512	7,045		152,339	(205,453)
Income tax (benefit) expense	(6,944)	1,253		(823)	32,786
Net income (loss)	110,456	5,792		153,162	(238,239)
Less: Net income attributable to noncontrolling interests	1,956	328		2,894	445
Net income (loss) attributable to A&F	$ 108,500	$ 5,464		$ 150,268	$ (238,684)
Net income (loss) per share attributable to A&F
Basic	$ 1.77	$ 0.09		$ 2.43	$ (3.82)
Diluted	$ 1.69	$ 0.09		$ 2.32	$ (3.82)
Weighted-average shares outstanding
Basic	61,428	62,527		61,914	62,543
Diluted	64,136	63,286		64,803	62,543
Other comprehensive income (loss)
Foreign currency translation, net of tax	$ (1,986)	$ 8,734		$ (3,260)	$ 3,335
Derivative financial instruments, net of tax	2,703	(2,407)		5,302	6,458
Other comprehensive income	717	6,327	[1]	2,042	9,793
Comprehensive income (loss)	111,173	12,119		155,204	(228,446)
Less: Comprehensive income attributable to noncontrolling interests	1,956	328		2,894	445
Comprehensive income (loss) attributable to A&F	$ 109,217	$ 11,791		$ 152,310	$ (228,891)
[1]	No income tax benefit was recognized during the period due to the establishment of a valuation allowance.

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jul. 31, 2021	Jan. 30, 2021
Current assets:
Cash and equivalents	$ 921,504	$ 1,104,862
Receivables	87,151	83,857
Inventories	415,604	404,053
Other current assets	77,392	68,857
Total current assets	1,501,651	1,661,629
Property and equipment, net	532,795	550,587
Operating lease right-of-use assets	791,036	893,989
Other assets	229,911	208,697
Total assets	3,055,393	3,314,902
Current liabilities:
Accounts payable	289,475	289,396
Accrued expenses	351,991	396,365
Short-term portion of operating lease liabilities	219,453	248,846
Income taxes payable	26,260	24,792
Total current liabilities	887,179	959,399
Long-term liabilities:
Long-term portion of operating lease liabilities	791,793	957,588
Long-term portion of borrowings, net	303,015	343,910
Other liabilities	106,473	104,693
Total long-term liabilities	1,201,281	1,406,191
Stockholders’ equity
Class A Common Stock - $0.01 par value: 150,000 shares authorized and 103,300 shares issued for all periods presented	1,033	1,033
Paid-in capital	399,891	401,283
Retained earnings	2,275,009	2,149,470
Accumulated other comprehensive loss, net of tax (“AOCL”)	(100,265)	(102,307)
Treasury stock, at average cost: 43,609 and 40,901 shares as of July 31, 2021 and January 30, 2021, respectively	(1,619,102)	(1,512,851)
Total Abercrombie & Fitch Co. stockholders’ equity	956,566	936,628
Noncontrolling interests	10,367	12,684
Total stockholders’ equity	966,933	949,312
Total liabilities and stockholders’ equity	$ 3,055,393	$ 3,314,902

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Jul. 31, 2021	Jan. 30, 2021
Stockholders’ equity
Treasury Stock, at Average Cost (in shares)	43,609,000	41,365,000
Class A Common Stock
Stockholders’ equity
Class A Common Stock, par value	$ 0.01	$ 0.01
Class A Common Stock, shares authorized	150,000,000	150,000,000
Class A Common Stock, shares issued	103,300,000	103,300,000

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jul. 31, 2021	Aug. 01, 2020
Document Period End Date	Jul. 31, 2021
Operating activities
Net income (loss)	$ 153,162,000	$ (238,239,000)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	72,249,000	82,753,000
Asset impairment		51,011,000
Loss on disposal	2,188,000	7,617,000
(Benefit) Provision for deferred income taxes	(21,187,000)	23,037,000
Share-based compensation	14,937,000	8,906,000
Loss on extinguishment of debt	5,347,000	0
Changes in assets and liabilities:
Inventories	(11,849,000)	(18,378,000)
Accounts payable and accrued expenses	(63,562,000)	122,004,000
Operating lease right-of-use assets and liabilities	(93,040,000)	(20,266,000)
Income taxes	1,379,000	(7,379,000)
Other assets	(11,575,000)	29,940,000
Other liabilities	(1,554,000)	5,227,000
Net cash provided by operating activities	49,945,000	46,233,000
Investing activities
Purchases of property and equipment	(35,269,000)	(75,621,000)
Withdrawal from Rabbi Trust Assets	0	50,000,000
Net cash used for investing activities	(35,269,000)	(25,621,000)
Financing activities
Proceeds from Notes Payable	0	350,000,000
Repayments of Notes Payable	(46,969,000)	0
Proceeds from Short-term Debt	0	210,000,000
Repayments of Long-term Debt	0	(233,250,000)
Repayments of Short-term Debt	0	(210,000,000)
Payments of Debt Issuance Costs	(1,837,000)	(6,558,000)
Purchase of treasury stock	(135,249,000)	(15,172,000)
Payments of Ordinary Dividends, Common Stock	0	12,556,000
Other financing activities	(16,192,000)	(11,135,000)
Net cash (used for) provided by financing activities	(200,247,000)	71,329,000
Effect of foreign currency exchange rates on cash	(2,547,000)	1,785,000
Net (decrease) increase in cash and equivalents, and restricted cash and equivalents	(188,118,000)	93,726,000
Cash and equivalents, and restricted cash, beginning of period	1,124,157,000	692,264,000
Cash and equivalents, and restricted cash and equivalents, end of period	936,039,000	785,990,000
Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]
Purchases of property and equipment not yet paid at end of period	35,789,000	34,865,000
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	17,159,000	23,119,000
Cash paid for interest	14,950,000	8,127,000
Cash paid for income taxes	24,132,000	8,460,000
Cash received from income tax refunds	570,000	1,426,000
Cash paid for operating lease liabilities	$ 230,836,000	$ 122,128,000

Consolidated Statements of Stoc

Consolidated Statements of Stockholders Equity Statement - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Noncontrolling Interest [Member]	Retained Earnings [Member]	AOCI Including Portion Attributable to Noncontrolling Interest [Member]	Treasury Stock [Member]
Shares, Outstanding		62,786					40,514
Total Abercrombie & Fitch Co. stockholders’ equity		$ 1,033	$ 404,983		$ 2,313,745	$ (108,886)	$ (1,552,065)
Noncontrolling interests				$ 12,368
Total stockholders' equity	$ 1,071,178
Income (Loss) Attributable to Noncontrolling Interest, before Tax				445
Net Income (Loss) Attributable to Parent	(238,684)				(238,684)
Net income (loss)	(238,239)
Treasury Stock, Shares, Acquired		(1,397)					1,397
Treasury Stock, Value, Acquired, Cost Method	(15,172)						$ (15,172)
Dividends	(12,556)				(12,556)
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture		976					(976)
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	(5,416)		(21,617)		(36,594)		$ 52,795
Share-based compensation expense	(8,906)		(8,906)
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax	6,458
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	3,335
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders	(4,884)			(4,884)
Shares, Outstanding		62,284					41,016
Total Abercrombie & Fitch Co. stockholders’ equity		$ 1,033	389,904		2,022,366	(105,420)	$ (1,517,644)
Noncontrolling interests				7,827
Total stockholders' equity	798,066
Income (Loss) Attributable to Noncontrolling Interest, before Tax				328
Net Income (Loss) Attributable to Parent	5,464				5,464
Net income (loss)	5,792
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture		81					(81)
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	(93)		(1,376)		(1,919)		$ 3,202
Share-based compensation expense	(3,744)		(3,744)
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax	(2,407)
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	8,734
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders	(226)			(226)
Shares, Outstanding		62,365					40,935
Total Abercrombie & Fitch Co. stockholders’ equity		$ 1,033	392,272		2,025,911	(99,093)	$ (1,514,442)
Noncontrolling interests				7,929
Total stockholders' equity	813,610
Shares, Outstanding		62,399					40,901
Total Abercrombie & Fitch Co. stockholders’ equity	936,628	$ 1,033	401,283		2,149,470	(102,307)	$ (1,512,851)
Noncontrolling interests	12,684			12,684
Total stockholders' equity	949,312
Income (Loss) Attributable to Noncontrolling Interest, before Tax				2,894
Net Income (Loss) Attributable to Parent	150,268				150,268
Net income (loss)	153,162
Treasury Stock, Shares, Acquired		(3,451)					3,451
Treasury Stock, Value, Acquired, Cost Method	(135,249)						$ (135,249)
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture		743					(743)
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	(12,060)		(16,329)		(24,729)		$ 28,998
Share-based compensation expense	(14,937)		(14,937)
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax	5,302
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	(3,260)
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders	(5,211)			(5,211)
Shares, Outstanding		61,935					41,365
Total Abercrombie & Fitch Co. stockholders’ equity		$ 1,033	395,277		2,169,748	(100,982)	$ (1,523,902)
Noncontrolling interests				8,776
Total stockholders' equity	949,950
Income (Loss) Attributable to Noncontrolling Interest, before Tax				1,956
Net Income (Loss) Attributable to Parent	108,500				108,500
Net income (loss)	110,456
Treasury Stock, Shares, Acquired		(2,374)					2,374
Treasury Stock, Value, Acquired, Cost Method	(100,000)						$ (100,000)
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture		130					(130)
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	(312)		(1,873)		(3,239)		$ 4,800
Share-based compensation expense	(6,487)		(6,487)
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax	2,703
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	(1,986)
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders	(365)			(365)
Shares, Outstanding		59,691					43,609
Total Abercrombie & Fitch Co. stockholders’ equity	956,566	$ 1,033	$ 399,891		$ 2,275,009	$ (100,265)	$ (1,619,102)
Noncontrolling interests	10,367			$ 10,367
Total stockholders' equity	$ 966,933

Nature of Business (Notes)

Nature of Business (Notes)	6 Months Ended
	Jul. 31, 2021
Nature of Business [Abstract]
Nature of Business	Abercrombie & Fitch Co. (“A&F”), a company incorporated in Delaware in 1996, through its subsidiaries (collectively, A&F and its subsidiaries are referred to as “Abercrombie & Fitch” or the “Company”), is a global, digitally-led omnichannel retailer. The Company offers a broad assortment of apparel, personal care products and accessories for men, women and kids, which are sold primarily through its digital channels and Company-owned stores, as well as through various third-party arrangements. The Company’s two brand-based operating segments are Hollister, which includes the Company’s Hollister, Gilly Hicks and Social Tourist brands, and Abercrombie, which includes the Company’s Abercrombie & Fitch and abercrombie kids brands. These five brands share a commitment to offering unique products of enduring quality and exceptional comfort that allow customers around the world to express their own individuality and style. The Company operates primarily in North America, Europe and Asia.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jul. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Significant Accounting Policies [Text Block]	Principles of consolidation The accompanying Condensed Consolidated Financial Statements include historical financial statements of, and transactions applicable to, the Company and reflect its financial position, results of operations and cash flows. The Company has interests in an Emirati business venture and in a Kuwaiti business venture with Majid al Futtaim Fashion L.L.C. (“MAF”) and in a U.S. business venture with Dixar L.L.C. (“Dixar”), each of which meets the definition of a variable interest entity (“VIE”). The purpose of these business ventures with MAF is to operate stores in the United Arab Emirates and Kuwait and the purpose of the business venture with Dixar is to hold the intellectual property related to the Social Tourist brand. The Company is deemed to be the primary beneficiary of these VIEs; therefore, the Company has consolidated the operating results, assets and liabilities of these VIEs, with the noncontrolling interests’ (“NCI”) portions of net income presented as net income attributable to NCI on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) and the NCI portion of stockholders equity presented as NCI on the Condensed Consolidated Balance Sheets. Fiscal year The Company’s fiscal year ends on the Saturday closest to January 31. This typically results in a fifty-two week year, but occasionally gives rise to an additional week, resulting in a fifty-three week year. Fiscal years are designated in the Condensed Consolidated Financial Statements and notes, as well as the remainder of this Quarterly Report on Form 10-Q, by the calendar year in which the fiscal year commences. All references herein to the Company’s fiscal years are as follows: Fiscal year Year ended/ ending Number of weeks Fiscal 2019 February 1, 2020 52 Fiscal 2020 January 30, 2021 52 Fiscal 2021 January 29, 2022 52 Interim financial statements The Condensed Consolidated Financial Statements as of July 31, 2021, and for the thirteen and twenty-six week periods ended July 31, 2021 and August 1, 2020, are unaudited and are presented pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim consolidated financial statements. Accordingly, the Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and notes thereto contained in A&F’s Annual Report on Form 10-K for Fiscal 2020 filed with the SEC on March 29, 2021. The January 30, 2021 consolidated balance sheet data, included herein, was derived from audited consolidated financial statements, but do not include all disclosures required by accounting principles generally accepted in the United States of America (“GAAP”). In the opinion of management, the accompanying Condensed Consolidated Financial Statements reflect all adjustments (which are of a normal recurring nature) necessary to state fairly, in all material respects, the financial position, results of operations and cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for Fiscal 2021. Use of estimates The preparation of financial statements, in conformity with GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of net sales and expenses during the reporting period. Due to the inherent uncertainty involved with estimates, actual results may differ. The extent to which the current outbreak of coronavirus disease (“COVID-19”) continues to impact the Company’s business and financial results will depend on numerous evolving factors including, but not limited to: the duration and spread of COVID-19 and the emergence of new variants, such as the Delta variant, of the coronavirus, the availability and acceptance of effective vaccines, boosters or medical treatments, the impact of COVID-19 on the length or frequency of store closures, and the extent to which COVID-19 impacts worldwide macroeconomic conditions including interest rates, the speed of the economic recovery, and governmental, business and consumer reactions to the pandemic. The Company’s assessment of these, as well as other factors, could impact management's estimates and result in material impacts to the Company’s consolidated financial statements in future reporting periods. Recent accounting pronouncements The Company reviews recent accounting pronouncements on a quarterly basis and has excluded discussion of those not applicable to the Company and those that did not have, or are not expected to have, a material impact on the Company’s consolidated financial statements. Restatement of previously issued financial information As previously disclosed within “ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA” of A&F’s Fiscal 2020 Form 10-K, a classification error was identified within the Company’s Condensed Consolidated Statements of Cash Flows in the Condensed Consolidated Financial Statements as of and for the periods ended May 2, 2020, August 1, 2020, and October 31, 2020, related to the presentation of the withdrawal of excess funds from the Company’s Rabbi Trust that occurred during the fiscal quarter ended May 2, 2020. This withdrawal of $50.0 million was originally presented incorrectly as a cash inflow from operating activities, rather than as a cash inflow from investing activities. The effects of the classification error on the Condensed Consolidated Statement of Cash Flows were disclosed in “Note 21. Correction of Error in Previously Reported Interim Financial Statements (Unaudited)” of the Notes to Consolidated Financial Statements included within “ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA” of A&F’’s Fiscal 2020 Form 10-K. The effects of the classification error on the Condensed Consolidated Statement of Cash Flow for the twenty-six weeks ended August 1, 2020 is shown in the table below. Twenty-six Weeks Ended As Originally Reported As Restated (in thousands) August 1, 2020 Adjustment August 1, 2020 Net cash provided by operating activities $ 96,233 $ (50,000) $ 46,233 Net cash used for investing activities $ (75,621) $ 50,000 $ (25,621) Net cash provided by financing activities $ 71,329 — $ 71,329 Effect of foreign currency exchange rates on cash $ 1,785 — $ 1,785 Net increase in cash and equivalents, and restricted cash and equivalents $ 93,726 — $ 93,726 Cash and equivalents, and restricted cash and equivalents, beginning of period $ 692,264 — $ 692,264 Cash and equivalents, and restricted cash and equivalents, end of period $ 785,990 — $ 785,990 The Company’s Condensed Consolidated Statement of Cash Flows for the twenty-six weeks ended August 1, 2020 included within this Quarterly Report on Form 10-Q has been restated to reflect the correction of this error. Condensed Consolidated Statements of Cash Flows reconciliation The following table provides a reconciliation of cash and equivalents and restricted cash and equivalents to the amounts shown on the Condensed Consolidated Statements of Cash Flows: (in thousands) Location July 31, 2021 January 30, 2021 August 1, 2020 February 1, 2020 Cash and equivalents Cash and equivalents $ 921,504 $ 1,104,862 $ 766,721 $ 671,267 Long-term restricted cash and equivalents Other assets 14,268 14,814 19,269 18,696 Short-term restricted cash and equivalents Other current assets 267 4,481 — 2,301 Cash and equivalents and restricted cash and equivalents $ 936,039 $ 1,124,157 $ 785,990 $ 692,264
BASIS OF PRESENTATION	Interim financial statements The Condensed Consolidated Financial Statements as of July 31, 2021, and for the thirteen and twenty-six week periods ended July 31, 2021 and August 1, 2020, are unaudited and are presented pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim consolidated financial statements. Accordingly, the Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and notes thereto contained in A&F’s Annual Report on Form 10-K for Fiscal 2020 filed with the SEC on March 29, 2021. The January 30, 2021 consolidated balance sheet data, included herein, was derived from audited consolidated financial statements, but do not include all disclosures required by accounting principles generally accepted in the United States of America (“GAAP”). In the opinion of management, the accompanying Condensed Consolidated Financial Statements reflect all adjustments (which are of a normal recurring nature) necessary to state fairly, in all material respects, the financial position, results of operations and cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for Fiscal 2021.

Impact of COVID-19 (Notes)

Impact of COVID-19 (Notes)	3 Months Ended
	Aug. 01, 2020
Unusual or Infrequent Item, or Both [Line Items]
Unusual or Infrequent Items, or Both, Disclosure [Text Block]	In March 2020, the COVID-19 outbreak was declared to be a global pandemic by the World Health Organization. In response to COVID-19, certain governments imposed travel restrictions and local statutory quarantines and the Company experienced widespread temporary store closures. The Company has seen, and may continue to see, material adverse impacts as a result of COVID-19. The extent of future impacts of COVID-19 on the Company’s business, including the duration and impact on overall customer demand, are uncertain as current circumstances are dynamic and depend on future developments, including, but not limited to, the duration and spread of COVID-19, the emergence of new variants of the coronavirus, such as the Delta variant, and the availability and acceptance of effective vaccines, boosters or medical treatments. During the thirteen and twenty-six weeks ended August 1, 2020, the Company experienced a material adverse impact to net sales across brands and regions as a result of widespread temporary store closures in response to COVID-19, which was not offset by year-over-year digital sales growth. During the thirteen and twenty-six weeks ended July 31, 2021, the vast majority of Company-operated stores were fully open for in-store service, but temporary store closures remained in the EMEA region during this period. As of July 31, 2021, all of the Company-operated stores were open for in-store service. During periods of temporary store closures, reductions in revenue were not offset by proportional decreases in expense, as the Company continued to incur store occupancy costs such as operating lease costs, net of rent abatements agreed upon during the period, depreciation expense, and certain other costs such as compensation, net of government payroll relief, and administrative expenses resulting in a negative effect on the relationship between the Company’s costs and revenues. During the thirteen weeks ended May 2, 2020, the Company recognized $14.8 million of charges to reduce the carrying value of inventory, primarily as a result of COVID-19 and the temporary closure of the Company’s stores, in cost of sales, exclusive of depreciation and amortization on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss). During the thirteen and twenty-six weeks ended July 31, 2021 and August 1, 2020, the Company suspended rent payments for a number of stores that were closed, and continues to engage with its landlords to find a mutually beneficial and agreeable path forward. The Company obtained rent abatements of $5.2 million and $13.0 million, respectively, during the thirteen and twenty-six weeks ended July 31, 2021 and recognized all of the benefits related to these abatements within variable lease cost during the applicable periods. Rent abatements obtained during the thirteen and twenty-six weeks ended August 1, 2020 were not significant. As of July 31, 2021 and January 30, 2021, the Company had $22.2 million and $24.2 million, respectively, related to suspended payments classified within accrued expenses on the Condensed Consolidated Balance Sheets. During the thirteen weeks ended July 31, 2021 and August 1, 2020, the Company recognized qualified payroll-related credits reducing payroll expenses by approximately $0.5 million and $3.1 million, respectively, in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss). During the twenty-six weeks ended July 31, 2021 and August 1, 2020, the Company recognized qualified payroll-related credits reducing payroll expenses by approximately $4.8 million and $11.8 million, respectively, in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss). There are also instances where governments have provided wage subsidies through direct payments to the Company’s associates. In these instances, no benefits are recognized on the Consolidated Statements of Operations and Comprehensive Income (Loss), but the Company does see a reduction in expense incurred. The Company also intends to continue to defer qualified payroll and other tax payments as permitted by regional legislation. During the thirteen and twenty-six weeks ended August 1, 2020, the Company recognized significant asset impairment charges related to the Company’s operating lease right-of-use assets and property and equipment of $8.1 million and $51.0 million, respectively, which were principally the result of the impact of COVID-19 on store cash flows. Refer to Note 9, “ ASSET IMPAIRMENT ,” for additional information. The Company has also experienced other material impacts as a result of COVID-19, such as deferred tax valuation allowances and other tax charges. Refer to Note 10, “ INCOME TAXES ,” for additional information. In March 2020, in an effort to improve the Company’s then near-term cash position as a precautionary measure in response to COVID-19, the Company borrowed $210.0 million under its senior secured asset-based revolving credit facility (the “ABL Facility”) and withdrew the majority of excess funds from the overfunded Rabbi Trust assets, providing the Company with $50.0 million of additional cash. In July 2020, the Company took additional actions to preserve liquidity in light of the continued global uncertainty then presented by COVID-19, and completed a private offering of $350.0 million aggregate principal amount of senior secured notes (the “Senior Secured Notes”). The Company used the net proceeds of such offering to repay all outstanding borrowings under the Company’s term loan facility (the “Term Loan Facility”), to repay a portion of the outstanding borrowings under the ABL Facility and to pay fees and expenses in connection with such repayments and the offering.

Revenue Recognition (Notes)

Revenue Recognition (Notes)	6 Months Ended
	Jul. 31, 2021
Revenue Recognition [Abstract]
Revenue from Contract with Customer [Text Block]	Disaggregation of revenue All revenues are recognized in net sales in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss). For information regarding the disaggregation of revenue, refer to Note 15, “ SEGMENT REPORTING . ” Contract liabilities The following table details certain contract liabilities representing unearned revenue as of July 31, 2021, January 30, 2021, August 1, 2020 and February 1, 2020: (in thousands) July 31, 2021 January 30, 2021 August 1, 2020 February 1, 2020 Gift card liability $ 29,038 $ 28,561 $ 22,461 $ 28,844 Loyalty program liability $ 20,962 $ 20,426 $ 19,674 $ 23,051 The following table details recognized revenue associated with the Company’s gift card program and loyalty programs for the thirteen and twenty-six weeks ended July 31, 2021 and August 1, 2020: Thirteen Weeks Ended Twenty-six Weeks Ended (in thousands) July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 Revenue associated with gift card redemptions and gift card breakage $ 17,353 $ 10,066 $ 33,509 $ 21,075 Revenue associated with reward redemptions and breakage related to the Company’s loyalty programs $ 9,897 $ 7,982 $ 19,450 $ 13,691

Net Income (Loss) Per Share

Net Income (Loss) Per Share	6 Months Ended
	Jul. 31, 2021
Earnings Per Share [Abstract]
NET LOSS PER SHARE	Net income (loss) per basic and diluted share attributable to A&F is computed based on the weighted-average number of outstanding shares of Class A Common Stock (“Common Stock”). Additional information pertaining to net income (loss) per share attributable to A&F follows: Thirteen Weeks Ended Twenty-six Weeks Ended (in thousands) July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 Shares of Common Stock issued 103,300 103,300 103,300 103,300 Weighted-average treasury shares (41,872) (40,773) (41,386) (40,757) Weighted-average — basic shares 61,428 62,527 61,914 62,543 Dilutive effect of share-based compensation awards 2,708 759 2,889 — Weighted-average — diluted shares 64,136 63,286 64,803 62,543 Anti-dilutive shares (1) 1,194 2,026 1,277 2,123 (1) Reflects the total number of shares related to outstanding share-based compensation awards that have been excluded from the computation of net income (loss) per diluted share because the impact would have been anti-dilutive. Unvested shares related to restricted stock units with performance-based and market-based vesting conditions can achieve up to 200% of their target vesting amount and are reflected at the maximum vesting amount less any dilutive portion.

Fair Value

Fair Value	6 Months Ended
	Jul. 31, 2021
Fair Value Disclosures [Abstract]
FAIR VALUE	Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The inputs used to measure fair value are prioritized based on a three-level hierarchy. The three levels of inputs to measure fair value are as follows: • Level 1—inputs are unadjusted quoted prices for identical assets or liabilities that are available in active markets that the Company can access at the measurement date. • Level 2—inputs are other than quoted market prices included within Level 1 that are observable for assets or liabilities, directly or indirectly. • Level 3—inputs to the valuation methodology are unobservable. The lowest level of significant input determines the placement of the entire fair value measurement in the hierarchy. The three levels of the hierarchy and the distribution of the Company’s assets and liabilities that were measured at fair value on a recurring basis, as of July 31, 2021 and January 30, 2021, were as follows: Assets and Liabilities at Fair Value as of July 31, 2021 (in thousands) Level 1 Level 2 Level 3 Total Assets: Cash equivalents (1) $ 131,301 $ 46,598 $ — $ 177,899 Derivative instruments (2) — 1,872 — 1,872 Rabbi Trust assets (3) 1 61,538 — 61,539 Restricted cash equivalents (1) 3,109 4,798 — 7,907 Total assets $ 134,411 $ 114,806 $ — $ 249,217 Liabilities: Derivative instruments (2) $ — $ 794 $ — $ 794 Total liabilities $ — $ 794 $ — $ 794 Assets and Liabilities at Fair Value as of January 30, 2021 (in thousands) Level 1 Level 2 Level 3 Total Assets: Cash equivalents (1) $ 296,279 $ 11,589 $ — $ 307,868 Derivative instruments (2) — 79 — 79 Rabbi Trust assets (3) 1 60,789 — 60,790 Restricted cash equivalents (1) 2,943 7,775 — 10,718 Total assets $ 299,223 $ 80,232 $ — $ 379,455 Liabilities: Derivative instruments (2) $ — $ 4,694 $ — $ 4,694 Total liabilities $ — $ 4,694 $ — $ 4,694 (1) Level 1 assets consisted of investments in money market funds. Level 2 assets consisted of time deposits. (2) Level 2 assets and liabilities consisted primarily of foreign currency exchange forward contracts. (3) Level 1 assets consisted of investments in money market funds. Level 2 assets consisted of trust-owned life insurance policies. The Company’s Level 2 assets and liabilities consisted of: • Time deposits, which were valued at cost, approximating fair value, due to the short-term nature of these investments; • Trust-owned life insurance policies, which were valued using the cash surrender value of the life insurance policies; and • Derivative instruments, primarily foreign currency exchange forward contracts, which were valued using quoted market prices of the same or similar instruments, adjusted for counterparty risk. Fair value of long-term borrowings The Company’s borrowings under the Senior Secured Notes are carried at historical cost in the accompanying Condensed Consolidated Balance Sheets. The carrying amount and fair value of the Company’s long-term gross borrowings were as follows: (in thousands) July 31, 2021 January 30, 2021 Gross borrowings outstanding, carrying amount $ 307,730 $ 350,000 Gross borrowings outstanding, fair value $ 340,811 $ 389,813

Property and Equipment, Net

Property and Equipment, Net	6 Months Ended
	Jul. 31, 2021
Property, Plant and Equipment [Abstract]
PROPERTY AND EQUIPMENT, NET	Property and equipment, net consisted of: (in thousands) July 31, 2021 January 30, 2021 Property and equipment, at cost $ 2,485,623 $ 2,488,957 Less: Accumulated depreciation and amortization (1,952,828) (1,938,370) Property and equipment, net $ 532,795 $ 550,587 Refer to Note 9, “ ASSET IMPAIRMENT ,” for details related to property and equipment impairment charges incurred during the thirteen and twenty-six weeks ended July 31, 2021 and August 1, 2020.

Leases (Notes)

Leases (Notes)	6 Months Ended
	Jul. 31, 2021
Leases [Abstract]
Leases of Lessee Disclosure [Text Block]	The Company is a party to leases related to its Company-operated retail stores as well as for certain of its distribution centers, office space, information technology and equipment. The following table provides a summary of the Company’s operating lease costs for the thirteen and twenty-six weeks ended July 31, 2021 and August 1, 2020: Thirteen Weeks Ended Twenty-six Weeks Ended (in thousands) July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 Single lease cost (1) $ 70,325 $ 87,698 $ 140,077 $ 181,189 Variable lease cost (2) 19,300 19,433 42,466 47,335 Operating lease right-of-use asset impairment (3) 240 5,410 2,704 40,418 Sublease income (4) (1,095) — (2,188) — Total operating lease cost $ 88,770 $ 112,541 $ 183,059 $ 268,942 (1) Included amortization and interest expense associated with operating lease right-of-use assets and the impact from remeasurement of operating lease liabilities. (2) Included variable payments related to both lease and nonlease components, such as contingent rent payments made by the Company based on performance, and payments related to taxes, insurance, and maintenance costs, as well as the benefit of $5.2 million and $13.0 million of rent abatements during the thirteen and twenty-six weeks ended July 31, 2021 related to the effects of the COVID-19 pandemic that resulted in the total payments required by the modified contract being substantially the same as or less than total payments required by the original contract. Rent abatements obtained during the thirteen and twenty-six weeks ended August 1, 2020 were not significant. (3) Refer to Note 9, “ ASSET IMPAIRMENT ,” for details related to operating lease right-of-use asset impairment charges. (4) The terms of the sublease agreement entered into by the Company with a third party during Fiscal 2020 related to one of its previous flagship store locations have not changed materially from that disclosed in Note 8, “LEASES,” of the Notes to Consolidated Financial Statements contained in “ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA” of A&F’s Annual Report on Form 10-K for Fiscal 2020. Sublease income is recognized in other operating income (loss), net on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss). During the thirteen and twenty-six weeks ended July 31, 2021 and August 1, 2020, the Company suspended rent payments for a number of stores that were closed as a result of COVID-19, and has been successful in obtaining certain rent abatements and landlord concessions of rent payable. Refer to Note 3. “ IMPACT OF COVID-19 ”, for additional details. As of July 31, 2021, the Company had minimum commitments related to additional operating lease contracts the terms of which have not yet commenced, primarily for its Company-operated retail stores, of approximately $2.5 million.

Asset Impairment (Notes)

Asset Impairment (Notes)	6 Months Ended
	Jul. 31, 2021
Asset Impairment [Abstract]
Asset Impairment [Text Block]	Asset impairment charges for the thirteen and twenty-six weeks ended July 31, 2021 and August 1, 2020 were as follows: Thirteen Weeks Ended Twenty-six Weeks Ended (in thousands) July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 Operating lease right-of-use asset impairment $ 240 $ 5,410 $ 2,704 $ 40,418 Property and equipment asset impairment 546 2,673 746 10,593 Total asset impairment $ 786 $ 8,083 $ 3,450 $ 51,011 Asset impairment charges for the thirteen and twenty-six weeks ended July 31, 2021 related to certain of the Company’s stores across brands, geographies and store formats. The impairment charges for the twenty-six weeks ended July 31, 2021 reduced the then carrying amount of the impaired stores’ assets to their fair value of approximately $9.4 million, including $8.8 million related to operating lease right-of-use assets. Asset impairment charges for the thirteen and twenty-six weeks ended August 1, 2020 were principally the result of the impact of COVID-19 and were related to certain of the Company’s stores across brands, geographies and store formats. The impairment charges for the twenty-six weeks ended August 1, 2020 reduced the then carrying amount of the impaired stores’ assets to their fair value of approximately $135.5 million, including $124.6 million related to operating lease right-of-use assets.

Income Taxes

Income Taxes	6 Months Ended
	Jul. 31, 2021
Income Tax Disclosure [Abstract]
INCOME TAXES	The quarterly provision for income taxes is based on the current estimate of the annual effective income tax rate and the tax effect of discrete items occurring during the quarter. The Company’s quarterly provision and the estimate of the annual effective tax rate are subject to significant variation due to several factors. These factors include variability in the pre-tax jurisdictional mix of earnings, changes in how the Company does business including entering into new businesses or geographies, changes in foreign currency exchange rates, changes in laws, regulations, interpretations and administrative practices, relative changes in expenses or losses for which tax benefits are not recognized and the impact of discrete items. In addition, jurisdictions where the Company anticipates an ordinary loss for the fiscal year for which the Company does not anticipate future benefits are excluded from the overall computation of estimated annual effective tax rate and no tax benefits are recognized in the period related to losses in such jurisdictions. The impact of these items on the effective tax rate will be greater at lower levels of pre-tax earnings. Impact of valuation allowances and other tax charges During the thirteen weeks ended July 31, 2021, as a result of the improvement seen in business conditions, the Company recognized $23.5 million of discrete tax benefits due to the release of valuation allowances, primarily in the U.S. and Germany, and a discrete tax benefit of $3.9 million due to the impact of a statutory rate change in the U.K on the valuation of deferred tax assets. The Company also recognized $6.7 million of tax benefits related to the utilization of deferred tax assets against projected pre-tax income for the full fiscal year, primarily in the U.S. and Germany, based on information available, on which a valuation allowance had previously been established. During the twenty-six weeks ended July 31, 2021, as a result of the improvement seen in business conditions, the Company recognized $23.6 million of discrete tax benefits due to the release of valuation allowances, primarily in the U.S. and Germany, and a discrete tax benefit of $3.9 million due to the impact of a statutory rate change in the U.K on the valuation of deferred tax assets. The Company also recognized $10.1 million of tax benefits related to the utilization of deferred tax assets against projected pre-tax income for the full fiscal year, primarily in the U.S. and Germany, based on information available, on which a valuation allowance had previously been established. The Company continues to maintain valuation allowances in certain jurisdictions, principally Japan, Korea, and Switzerland. During the twenty-six weeks ended August 1, 2020, the Company recognized $84.1 million of tax charges, ultimately giving rise to income tax expense on a consolidated pre-tax year-to-date loss. Further details regarding these adverse tax impacts are as follows: • The Company anticipated pre-tax losses for the full fiscal year in certain jurisdictions, based on information then available, primarily due to the significant adverse impacts of COVID-19. The Company did not recognize income tax benefits on $204.1 million of pre-tax losses during the twenty-six weeks ended August 1, 2020, resulting in an adverse tax impact of $47.6 million. • The Company recognized charges of $36.5 million related to the establishment of valuation allowances and other tax charges in certain jurisdictions during the twenty-six weeks ended August 1, 2020, principally as a result of the significant adverse impacts of COVID–19. These charges related to valuation allowances recognized by the Company of $10.6 million and $6.0 million related to the U.S. and Germany, respectively, as well as valuation allowances and other tax charges in certain other jurisdictions against underlying tax asset balances that existed as of February 1, 2020. The Company also recognized valuation allowances of $78.9 million related to Switzerland with a U.S. branch equally offsetting amount, which in net, did not have an impact on the Condensed Consolidated Statement of Operations and Comprehensive Income (Loss). The Company continues to review the need for valuation allowances in certain jurisdictions, principally Japan, Korea and Switzerland, on a quarterly basis. It is reasonably possible, if business conditions continue to improve, that there could be material adjustments over the next 12 months to the total amount of valuation allowances as circumstances may be such that sufficient evidence would exist to indicate that additional deferred taxes currently subject to a valuation allowance are more likely than not to be utilized. Changes in assumptions may occur based on new information that becomes available resulting in adjustments in the period in which a determination is made. Share-based compensation Refer to Note 12, “ SHARE-BASED COMPENSATION ,” for details on income tax benefits and charges related to share-based compensation awards during the thirteen and twenty-six weeks ended July 31, 2021 and August 1, 2020.

Borrowings

Borrowings	6 Months Ended
	Jul. 31, 2021
Debt Disclosure [Abstract]
Borrowings	Details on the Company’s long-term borrowings, net, as of July 31, 2021 and January 30, 2021 are as follows: (in thousands) July 31, 2021 January 30, 2021 Long-term portion of borrowings, gross at carrying amount $ 307,730 $ 350,000 Unamortized fees (4,715) (6,090) Long-term borrowings, net $ 303,015 $ 343,910 Senior Secured Notes On July 2, 2020, Abercrombie & Fitch Management Co. (“A&F Management”), a wholly-owned indirect subsidiary of A&F, completed the private offering of the Senior Secured Notes, with $350.0 million aggregate principal amount due in 2025, at an offering price of 100% of the principal amount thereof and bearing interest at a rate of 8.75% per annum, with semi-annual interest payments which began in January 2021. The Senior Secured Notes were issued pursuant to an indenture, dated as of July 2, 2020, by and among A&F Management, A&F and certain of A&F’s wholly-owned subsidiaries, as guarantors, and U.S. Bank National Association, as trustee, and as collateral agent. During the thirteen weeks ended July 31, 2021, A&F Management purchased $42.3 million of its outstanding Senior Secured Notes and incurred $5.3 million of loss on extinguishment of debt, comprised of a premium of $4.7 million and the write-off of unamortized fees of $0.6 million, in interest expense, net on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss). The terms of the Senior Secured Notes have not changed materially from those disclosed in Note 13, “BORROWINGS,” of the Notes to Consolidated Financial Statements contained in “ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA” of A&F’s Annual Report on Form 10-K for Fiscal 2020. ABL Facility On April 29, 2021, A&F Management, in A&F Management’s capacity as the lead borrower, and the other borrowers and guarantors party thereto, amended and restated in its entirety the Credit Agreement, dated as of August 7, 2014, as amended on September 10, 2015 and as further amended on October 19, 2017 (as amended and restated, the “Amended and Restated Credit Agreement”), among A&F Management, the other borrowers and guarantors party thereto, the lenders party thereto, Wells Fargo Bank, National Association, as administrative agent for the lenders, and the other parties thereto. The Amended and Restated Credit Agreement continues to provide for a senior secured revolving credit facility of up to $400.0 million (the “ABL Facility”), and (i) extends the maturity date of the ABL Facility from October 19, 2022 to April 29, 2026; and (ii) modifies the required fee on undrawn commitments under the ABL Facility from 0.25% per annum to either 0.25% or 0.375% per annum (with the ultimate amount dependent on the conditions detailed in the Amended and Restated Credit Agreement). Except for these changes, the terms of the ABL Facility remained substantially unchanged from those disclosed in Note 13, “BORROWINGS,” of the Notes to Consolidated Financial Statements contained in “ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA” of A&F’s Annual Report on Form 10-K for Fiscal 2020. The Company did not have any borrowings outstanding under the ABL Facility as of July 31, 2021 or as of January 30, 2021. As of July 31, 2021, the Company had availability under the ABL Facility of $278.6 million, net of $0.8 million in outstanding stand-by letters of credit. As the Company must maintain excess availability equal to the greater of 10% of the loan cap or $30 million under the ABL Facility, borrowing available to the Company under the ABL Facility was $248.6 million as of July 31, 2021. Representations, warranties and covenants The agreements related to the Senior Secured Notes and the ABL Facility contain various representations, warranties and restrictive covenants that, among other things and subject to specified exceptions, restrict the ability of the Company and its subsidiaries to: grant or incur liens; incur, assume or guarantee additional indebtedness; sell or otherwise dispose of assets, including capital stock of subsidiaries; make investments in certain subsidiaries; pay dividends, make distributions or redeem or repurchase capital stock; change the nature of their business; and consolidate or merge with or into, or sell substantially all of the Company’s or A&F Management’s assets to, another entity. The Senior Secured Notes are guaranteed on a senior secured basis, jointly and severally, by A&F and each of the existing and future wholly-owned domestic restricted subsidiaries of A&F that guarantee or will guarantee A&F Management’s Amended and Restated Credit Agreement or certain future capital markets indebtedness. Certain of the agreements related to the Senior Secured Notes and the ABL Facility also contain certain affirmative covenants, including reporting requirements such as delivery of financial statements, certificates and notices of certain events, maintaining insurance and providing additional guarantees and collateral in certain circumstances. The Company was in compliance with all debt covenants under these agreements as of July 31, 2021.

Share-Based Compensation

Share-Based Compensation	6 Months Ended
	Jul. 31, 2021
Share-based Payment Arrangement [Abstract]
SHARE-BASED COMPENSATION	Financial statement impact The following table details share-based compensation expense and the related income tax impacts for the thirteen and twenty-six weeks ended July 31, 2021 and August 1, 2020: Thirteen Weeks Ended Twenty-six Weeks Ended (in thousands) July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 Share-based compensation expense $ 6,487 $ 3,744 $ 14,937 $ 8,906 Income tax benefit associated with share-based compensation expense recognized (1) $ 1,388 $ — $ 1,686 $ — (1) No income tax benefit was recognized during the thirteen and twenty-six weeks ended August 1, 2020 due to the establishment of a valuation allowance. The following table details discrete income tax benefits and charges related to share-based compensation awards during the thirteen and twenty-six weeks ended July 31, 2021 and August 1, 2020: Thirteen Weeks Ended Twenty-six Weeks Ended (in thousands) July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 Income tax discrete benefits realized for tax deductions related to the issuance of shares (1) $ 826 $ — $ 4,016 $ — Income tax discrete charges realized upon cancellation of stock appreciation rights (1) — — (3) — Total income tax discrete benefits related to share-based compensation awards (1) $ 826 $ — $ 4,013 $ — (1) No income tax benefit was recognized during the thirteen and twenty-six weeks ended August 1, 2020 due to the establishment of a valuation allowance. The following table details the amount of employee tax withheld by the Company upon the issuance of shares associated with restricted stock units vesting and the exercise of stock appreciation rights for the thirteen and twenty-six weeks ended July 31, 2021 and August 1, 2020: Thirteen Weeks Ended Twenty-six Weeks Ended (in thousands) July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 Employee tax withheld upon issuance of shares (1) $ 312 $ 93 $ 12,060 $ 5,416 (1) Classified within other financing activities on the Condensed Consolidated Statements of Cash Flows. Restricted stock units The following table summarizes activity for restricted stock units for the twenty-six weeks ended July 31, 2021: Service-based Restricted Performance-based Restricted Market-based Restricted Number of Weighted- Number of Weighted- Number of Weighted- Unvested at January 30, 2021 3,037,098 $ 11.62 297,216 $ 22.43 721,879 $ 21.46 Granted 659,612 32.38 146,580 31.78 73,294 49.81 Adjustments for performance achievement — — (106,715) 21.31 (6,084) 33.69 Vested (1,019,420) 12.19 — — (100,634) 33.69 Forfeited (45,199) 12.73 (1,704) 23.05 (10,657) 17.84 Unvested at July 31, 2021 (1) 2,632,091 $ 16.58 335,377 $ 26.87 677,798 $ 22.66 (1) Unvested shares related to restricted stock units with performance-based and market-based vesting conditions are reflected at 100% of their target vesting amount in the table above. Unvested shares related to restricted stock units with performance-based and market-based vesting conditions can be achieved at up to 200% of their target vesting amount. The following table details unrecognized compensation cost and the remaining weighted-average period over which these costs are expected to be recognized for restricted stock units as of July 31, 2021: (in thousands) Service-based Restricted Performance-based Restricted Market-based Restricted Unrecognized compensation cost $ 36,486 $ 5,076 $ 9,330 Remaining weighted-average period cost is expected to be recognized (years) 1.3 1.2 1.0 Additional information pertaining to restricted stock units for the twenty-six weeks ended July 31, 2021 and August 1, 2020 follows: (in thousands) July 31, 2021 August 1, 2020 Service-based restricted stock units: Total grant date fair value of awards granted $ 21,358 $ 13,752 Total grant date fair value of awards vested $ 12,427 $ 12,834 Performance-based restricted stock units: Total grant date fair value of awards granted $ 4,658 $ — Total grant date fair value of awards vested $ — $ 4,635 Market-based restricted stock units: Total grant date fair value of awards granted $ 3,651 $ — Total grant date fair value of awards vested $ 3,390 $ 4,132 No market-based restricted stock units were granted during the twenty-six weeks ended August 1, 2020. The weighted-average assumptions used for market-based restricted stock units in the Monte Carlo simulation during the twenty-six weeks ended July 31, 2021 were as follows: July 31, 2021 Grant date market price $ 31.78 Fair value $ 49.81 Assumptions: Price volatility 66 % Expected term (years) 2.9 Risk-free interest rate 0.3 % Dividend yield — % Average volatility of peer companies 72.0 % Average correlation coefficient of peer companies 0.4694 Stock appreciation rights The following table summarizes stock appreciation rights activity for the twenty-six weeks ended July 31, 2021: Number of Weighted-Average Aggregate Weighted-Average Outstanding at January 30, 2021 384,757 $ 33.04 Granted — — Exercised (107,068) 26.89 Forfeited or expired (34,150) 54.87 Outstanding at July 31, 2021 243,539 $ 32.69 $ 2,029,216 2.8 Stock appreciation rights exercisable at July 31, 2021 243,539 $ 32.69 $ 2,029,216 2.8 Stock appreciation rights expected to become exercisable in the future as of July 31, 2021 — $ — $ — 0.0 No stock appreciation rights were exercised during the twenty-six weeks ended August 1, 2020. Information pertaining to stock appreciation rights exercised during the twenty-six weeks ended July 31, 2021 follows: (in thousands) July 31, 2021 Total grant date fair value of awards exercised $ 1,020

Derivative Instruments

Derivative Instruments	6 Months Ended
	Jul. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE INSTRUMENTS	The Company is exposed to risks associated with changes in foreign currency exchange rates and uses derivative instruments, primarily forward contracts, to manage the financial impacts of these exposures. The Company does not use forward contracts to engage in currency speculation and does not enter into derivative financial instruments for trading purposes. The Company uses derivative instruments, primarily foreign currency exchange forward contracts designated as cash flow hedges, to hedge the foreign currency exchange rate exposure associated with forecasted foreign-currency-denominated intercompany inventory sales to foreign subsidiaries and the related settlement of the foreign-currency-denominated intercompany receivables. Fluctuations in foreign currency exchange rates will either increase or decrease the Company’s intercompany equivalent cash flows and affect the Company’s U.S. Dollar earnings. Gains or losses on the foreign currency exchange forward contracts that are used to hedge these exposures are expected to partially offset this variability. Foreign currency exchange forward contracts represent agreements to exchange the currency of one country for the currency of another country at an agreed upon settlement date. These foreign currency exchange forward contracts typically have a maximum term of twelve months. The sale of the inventory to the Company’s customers will result in the reclassification of related derivative gains and losses that are reported in AOCL into earnings. The Company also uses foreign currency exchange forward contracts to hedge certain foreign-currency-denominated net monetary assets/liabilities. Examples of monetary assets/liabilities include cash balances, receivables and payables. Fluctuations in foreign currency exchange rates result in transaction gains or losses being recorded in earnings, as U.S. GAAP requires that monetary assets/liabilities be remeasured at the spot exchange rate at quarter-end or upon settlement. The Company has chosen not to apply hedge accounting to these instruments because there are no differences in the timing of gain or loss recognition on the hedging instruments and the hedged items. As of July 31, 2021, the Company had outstanding the following foreign currency exchange forward contracts that were entered into to hedge either a portion, or all, of forecasted foreign-currency-denominated intercompany inventory sales, the resulting settlement of the foreign-currency-denominated intercompany accounts receivable, or both: (in thousands) Notional Amount (1) Euro $ 123,157 British pound $ 82,236 Canadian dollar $ 18,181 Japanese yen $ 7,120 (1) Amount reported is the U.S. Dollar notional amount outstanding as of July 31, 2021. The fair value of derivative instruments is valued using quoted market prices of the same or similar instruments, adjusted for counterparty risk. The location and amounts of derivative fair values of foreign currency exchange forward contracts on the Condensed Consolidated Balance Sheets as of July 31, 2021 and January 30, 2021 were as follows: (in thousands) Location July 31, 2021 January 30, 2021 Location July 31, 2021 January 30, 2021 Derivatives designated as cash flow hedging instruments Other current assets $ 1,872 $ 79 Accrued expenses $ 794 $ 4,694 Derivatives not designated as hedging instruments Other current assets — — Accrued expenses — — Total $ 1,872 $ 79 $ 794 $ 4,694 Information pertaining to derivative gains or losses from foreign currency exchange forward contracts designated as cash flow hedging instruments for the thirteen and twenty-six weeks ended July 31, 2021 and August 1, 2020 follows: Thirteen Weeks Ended Twenty-six Weeks Ended (in thousands) July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 Gain recognized in AOCL (1) $ 1,084 $ — $ 2,228 $ 12,235 (Loss) gain reclassified from AOCL to cost of sales, exclusive of depreciation and amortization (2) $ (1,697) $ 2,407 $ (3,152) $ 5,777 (1) Amount represents the change in fair value of derivative contracts. As a result of COVID-19, there was a significant change in the expected timing of previously hedged intercompany sales transactions, resulting in a dedesignation of the related hedge instruments during the twenty-six weeks ended August 1, 2020. At the time of dedesignation of these hedges, they were in a net gain position of approximately $12.6 million. Due to the extenuating circumstances leading to dedesignation, gains associated with these hedges at the time of dedesignation were deferred in AOCL until being reclassified into cost of goods sold, exclusive of depreciation and amortization when the originally forecasted transactions occurred and the hedged items affected earnings. Subsequent to the dedesignation of these hedges, these hedge contracts were settled in Fiscal 2020. (2) Amount represents (loss) gain reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) when the hedged item affects earnings, which is when merchandise is converted to cost of sales, exclusive of depreciation and amortization. Substantially all of the unrealized gain will be recognized in costs of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) over the next twelve months. Additional information pertaining to derivative gains or losses from foreign currency exchange forward contracts not designated as hedging instruments for the thirteen and twenty-six weeks ended July 31, 2021 and August 1, 2020 follows: Thirteen Weeks Ended Twenty-six Weeks Ended (in thousands) July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 Gain (loss) recognized in other operating income, net $ 304 $ — $ (164) $ 742

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	6 Months Ended
	Jul. 31, 2021
Equity [Abstract]
ACCUMULATED OTHER COMPREHENSIVE LOSS	r the thirteen and twenty-six weeks ended July 31, 2021, the activity in AOCL was as follows: Thirteen Weeks Ended July 31, 2021 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at May 1, 2021 $ (99,046) $ (1,936) $ (100,982) Other comprehensive (loss) income before reclassifications (1,986) 1,084 (902) Reclassified loss from accumulated other comprehensive loss (1) — 1,697 1,697 Tax effect — (78) (78) Other comprehensive (loss) income after reclassifications (1,986) 2,703 717 Ending balance at July 31, 2021 $ (101,032) $ 767 $ (100,265) Twenty-six Weeks Ended July 31, 2021 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at January 30, 2021 $ (97,772) $ (4,535) $ (102,307) Other comprehensive (loss) income before reclassifications (3,260) 2,228 (1,032) Reclassified loss from accumulated other comprehensive loss (1) — 3,152 3,152 Tax effect — (78) (78) Other comprehensive income after reclassifications (3,260) 5,302 2,042 Ending balance at July 31, 2021 $ (101,032) $ 767 $ (100,265) (1) Amount represents loss reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss). For the thirteen and twenty-six weeks ended August 1, 2020, the activity in AOCL was as follows: Thirteen Weeks Ended August 1, 2020 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at May 2, 2020 $ (115,366) $ 9,946 $ (105,420) Other comprehensive income before reclassifications 8,734 — 8,734 Reclassified gain from accumulated other comprehensive loss (1) — (2,407) (2,407) Other comprehensive (loss) income after reclassifications (2) 8,734 (2,407) 6,327 Ending balance at August 1, 2020 $ (106,632) $ 7,539 $ (99,093) Twenty-six Weeks Ended August 1, 2020 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at February 1, 2020 $ (109,967) $ 1,081 $ (108,886) Other comprehensive income before reclassifications 3,335 12,235 15,570 Reclassified gain from accumulated other comprehensive loss (1) — (5,777) (5,777) Other comprehensive (loss) income after reclassifications (2) 3,335 6,458 9,793 Ending balance at August 1, 2020 $ (106,632) $ 7,539 $ (99,093) (1) Amount represents gain reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss). (2) No income tax benefit was recognized during the period due to the establishment of a valuation allowance.

Segment Reporting

Segment Reporting	6 Months Ended
	Jul. 31, 2021
Segment Reporting [Abstract]
SEGMENT REPORTING	The Company’s two operating segments are brand-based: Hollister, which includes the Company’s Hollister, Gilly Hicks and Social Tourist brands, and Abercrombie, which includes the Company’s Abercrombie & Fitch and abercrombie kids brands. These operating segments have similar economic characteristics, classes of consumers, products, and production and distribution methods, operate in the same regulatory environments, and have been aggregated into one reportable segment. Amounts shown below include net sales from wholesale, franchise and licensing operations, which are not a significant component of total revenue, and are aggregated within their respective operating segment and geographic area. The Company’s net sales by operating segment for the thirteen and twenty-six weeks ended July 31, 2021 and August 1, 2020 were as follows: Thirteen Weeks Ended Twenty-six Weeks Ended (in thousands) July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 Hollister $ 514,483 $ 429,248 $ 956,891 $ 702,260 Abercrombie 350,367 269,080 689,364 481,427 Total $ 864,850 $ 698,328 $ 1,646,255 $ 1,183,687 Net sales by geographic area are presented by attributing revenues to an individual country on the basis of the country in which the merchandise was sold for in-store purchases and on the basis of the shipping location provided by customers for digital orders. The Company’s net sales by geographic area for the thirteen and twenty-six weeks ended July 31, 2021 and August 1, 2020 were as follows: Thirteen Weeks Ended Twenty-six Weeks Ended (in thousands) July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 U.S. $ 601,767 $ 458,671 $ 1,155,613 $ 781,533 EMEA 190,840 171,297 349,842 283,951 APAC 41,228 41,814 87,274 74,150 Other 31,015 26,546 53,526 44,053 International $ 263,083 $ 239,657 $ 490,642 $ 402,154 Total $ 864,850 $ 698,328 $ 1,646,255 $ 1,183,687

Flagship Store Exit (Benefits)

Flagship Store Exit (Benefits) Charges (Notes)	6 Months Ended
	Jul. 31, 2021
Flagship Store Exit Charges [Abstract]
Restructuring and Related Activities Disclosure [Text Block]	Reflecting a continued focus on one of the Company’s key transformation initiatives ‘Global Store Network Optimization,’ the Company continues to pivot away from its large format flagship stores and strives to open smaller, more productive omnichannel focused brand experiences. As a result, the Company has closed certain of its flagship stores and may have additional closures as it executes against this strategy. The Company recognizes impacts related to the exit of its flagship stores in flagship store exit benefits on the Consolidated Statements of Operations and Comprehensive Income (Loss). Details of the (benefits) charges recognized during the thirteen and twenty-six weeks ended July 31, 2021 and August 1, 2020 related to this initiative follow: Thirteen Weeks Ended Twenty-six Weeks Ended (in thousands) July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 Operating lease cost — (5,230) (841) (5,230) Asset disposals and other store-closure costs (1) — (3,205) (514) (3,205) Employee severance and other employee transition costs (88) 4,551 167 4,008 Total flagship store exit benefits $ (88) $ (3,884) $ (1,188) $ (4,427) (1) Amounts represent costs incurred or benefits realized associated with returning the store to its original condition, including updated estimates to previously established accruals for asset retirement obligations and costs to remove inventory and store assets. During the thirteen weeks ended May 1, 2021, the Company finalized an agreement with and paid its landlord partner to settle all remaining obligations related to the SoHo Hollister flagship store in New York City, which closed during the second quarter of Fiscal 2019. Prior to this new agreement, the Company was required to make payments in aggregate of $80.1 million pursuant to the lease agreements through the fiscal year ending January 30, 2029 (“Fiscal 2028”). The new agreement resulted in an acceleration of payments and provided for a discount resulting in a reduction of operating lease liabilities of $65.0 million and a cash outflow of $63.8 million to settle all remaining obligations related to this location. This cash outflow was classified within operating lease right-of-use assets and liabilities within Operating activities on the Condensed Consolidated Statement of Cash Flows during the twenty-six weeks ended July 31, 2021. The Company recognized a gain of $0.9 million in flagship store exit benefits on the Consolidated Statement of Operations and Comprehensive Income (Loss) related to this transaction. In addition, during Fiscal 2020, the Company announced the early exit of four European Abercrombie & Fitch flagship locations, Three of the leases were transferred through assignment while the fourth lease has been subleased to a new tenant. The Company no longer has lease obligations for the three transfers and is scheduled to receive payments to fully offset its lease obligations on the sublease. Refer to Note 8, “ LEASES ,” for additional information on the sublease arrangement. As the Company continues its ‘Global Store Network Optimization’ efforts, it may incur future cash expenditures or incremental charges or realize benefits not currently contemplated due to events that may occur as a result of, or that are associated with, previously announced flagship store closures and flagship store closures that have not yet been finalized. At this time, the Company is not able to quantify the amount of future impacts, including any cash expenditures that may take place in future periods resulting from any potential flagship store closures given the unpredictable nature of lease exit negotiations and ultimate lease renewal decisions.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies Principles of Consolidation (Policies)	6 Months Ended
	Jul. 31, 2021
Basis of Presentation [Abstract]
Consolidation, Policy [Policy Text Block]	Principles of consolidation The accompanying Condensed Consolidated Financial Statements include historical financial statements of, and transactions applicable to, the Company and reflect its financial position, results of operations and cash flows. The Company has interests in an Emirati business venture and in a Kuwaiti business venture with Majid al Futtaim Fashion L.L.C. (“MAF”) and in a U.S. business venture with Dixar L.L.C. (“Dixar”), each of which meets the definition of a variable interest entity (“VIE”). The purpose of these business ventures with MAF is to operate stores in the United Arab Emirates and Kuwait and the purpose of the business venture with Dixar is to hold the intellectual property related to the Social Tourist brand. The Company is deemed to be the primary beneficiary of these VIEs; therefore, the Company has consolidated the operating results, assets and liabilities of these VIEs, with the noncontrolling interests’ (“NCI”) portions of net income presented as net income attributable to NCI on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) and the NCI portion of stockholders equity presented as NCI on the Condensed Consolidated Balance Sheets.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies Fiscal Years (Policies)	6 Months Ended
	Jul. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Fiscal Period, Policy [Policy Text Block]	Fiscal year The Company’s fiscal year ends on the Saturday closest to January 31. This typically results in a fifty-two week year, but occasionally gives rise to an additional week, resulting in a fifty-three week year. Fiscal years are designated in the Condensed Consolidated Financial Statements and notes, as well as the remainder of this Quarterly Report on Form 10-Q, by the calendar year in which the fiscal year commences. All references herein to the Company’s fiscal years are as follows: Fiscal year Year ended/ ending Number of weeks Fiscal 2019 February 1, 2020 52 Fiscal 2020 January 30, 2021 52 Fiscal 2021 January 29, 2022 52

Summary of Significant Accoun_4

Summary of Significant Accounting Policies Recent Accounting Pronouncements (Tables)	6 Months Ended
	Jul. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Error Corrections and Prior Period Adjustments	The effects of the classification error on the Condensed Consolidated Statement of Cash Flow for the twenty-six weeks ended August 1, 2020 is shown in the table below. Twenty-six Weeks Ended As Originally Reported As Restated (in thousands) August 1, 2020 Adjustment August 1, 2020 Net cash provided by operating activities $ 96,233 $ (50,000) $ 46,233 Net cash used for investing activities $ (75,621) $ 50,000 $ (25,621) Net cash provided by financing activities $ 71,329 — $ 71,329 Effect of foreign currency exchange rates on cash $ 1,785 — $ 1,785 Net increase in cash and equivalents, and restricted cash and equivalents $ 93,726 — $ 93,726 Cash and equivalents, and restricted cash and equivalents, beginning of period $ 692,264 — $ 692,264 Cash and equivalents, and restricted cash and equivalents, end of period $ 785,990 — $ 785,990

Summary of Significant Accoun_5

Summary of Significant Accounting Policies Condensed Consolidated Statements of Cash Flows reconciliation (Tables)	6 Months Ended
	Jul. 31, 2021
Condensed Statements of Cash Flows reconciliation [Abstract]
Reconciliation of Cash and Equivalents to Restricted cash and Equivalents [Table Text Block]	Condensed Consolidated Statements of Cash Flows reconciliation The following table provides a reconciliation of cash and equivalents and restricted cash and equivalents to the amounts shown on the Condensed Consolidated Statements of Cash Flows: (in thousands) Location July 31, 2021 January 30, 2021 August 1, 2020 February 1, 2020 Cash and equivalents Cash and equivalents $ 921,504 $ 1,104,862 $ 766,721 $ 671,267 Long-term restricted cash and equivalents Other assets 14,268 14,814 19,269 18,696 Short-term restricted cash and equivalents Other current assets 267 4,481 — 2,301 Cash and equivalents and restricted cash and equivalents $ 936,039 $ 1,124,157 $ 785,990 $ 692,264

Revenue Recognition (Tables)

Revenue Recognition (Tables)	6 Months Ended
	Jul. 31, 2021
Revenue Recognition [Abstract]
Deferred Revenue, by Arrangement, Disclosure [Table Text Block]	The following table details certain contract liabilities representing unearned revenue as of July 31, 2021, January 30, 2021, August 1, 2020 and February 1, 2020: (in thousands) July 31, 2021 January 30, 2021 August 1, 2020 February 1, 2020 Gift card liability $ 29,038 $ 28,561 $ 22,461 $ 28,844 Loyalty program liability $ 20,962 $ 20,426 $ 19,674 $ 23,051 The following table details recognized revenue associated with the Company’s gift card program and loyalty programs for the thirteen and twenty-six weeks ended July 31, 2021 and August 1, 2020: Thirteen Weeks Ended Twenty-six Weeks Ended (in thousands) July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 Revenue associated with gift card redemptions and gift card breakage $ 17,353 $ 10,066 $ 33,509 $ 21,075 Revenue associated with reward redemptions and breakage related to the Company’s loyalty programs $ 9,897 $ 7,982 $ 19,450 $ 13,691

Net Income (Loss) Per Share (Ta

Net Income (Loss) Per Share (Table)	6 Months Ended
	Jul. 31, 2021
Earnings Per Share [Abstract]
Schedule of Weighted Average Number of Shares	Additional information pertaining to net income (loss) per share attributable to A&F follows: Thirteen Weeks Ended Twenty-six Weeks Ended (in thousands) July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 Shares of Common Stock issued 103,300 103,300 103,300 103,300 Weighted-average treasury shares (41,872) (40,773) (41,386) (40,757) Weighted-average — basic shares 61,428 62,527 61,914 62,543 Dilutive effect of share-based compensation awards 2,708 759 2,889 — Weighted-average — diluted shares 64,136 63,286 64,803 62,543 Anti-dilutive shares (1) 1,194 2,026 1,277 2,123 (1) Reflects the total number of shares related to outstanding share-based compensation awards that have been excluded from the computation of net income (loss) per diluted share because the impact would have been anti-dilutive. Unvested shares related to restricted stock units with performance-based and market-based vesting conditions can achieve up to 200% of their target vesting amount and are reflected at the maximum vesting amount less any dilutive portion.

Fair Value (Tables)

Fair Value (Tables)	6 Months Ended
	Jul. 31, 2021
Fair Value Disclosures [Abstract]
Company's Assets and Liabilities Measured at Fair Value	The three levels of the hierarchy and the distribution of the Company’s assets and liabilities that were measured at fair value on a recurring basis, as of July 31, 2021 and January 30, 2021, were as follows: Assets and Liabilities at Fair Value as of July 31, 2021 (in thousands) Level 1 Level 2 Level 3 Total Assets: Cash equivalents (1) $ 131,301 $ 46,598 $ — $ 177,899 Derivative instruments (2) — 1,872 — 1,872 Rabbi Trust assets (3) 1 61,538 — 61,539 Restricted cash equivalents (1) 3,109 4,798 — 7,907 Total assets $ 134,411 $ 114,806 $ — $ 249,217 Liabilities: Derivative instruments (2) $ — $ 794 $ — $ 794 Total liabilities $ — $ 794 $ — $ 794 Assets and Liabilities at Fair Value as of January 30, 2021 (in thousands) Level 1 Level 2 Level 3 Total Assets: Cash equivalents (1) $ 296,279 $ 11,589 $ — $ 307,868 Derivative instruments (2) — 79 — 79 Rabbi Trust assets (3) 1 60,789 — 60,790 Restricted cash equivalents (1) 2,943 7,775 — 10,718 Total assets $ 299,223 $ 80,232 $ — $ 379,455 Liabilities: Derivative instruments (2) $ — $ 4,694 $ — $ 4,694 Total liabilities $ — $ 4,694 $ — $ 4,694 (1) Level 1 assets consisted of investments in money market funds. Level 2 assets consisted of time deposits. (2) Level 2 assets and liabilities consisted primarily of foreign currency exchange forward contracts.
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis, Valuation Techniques [Table Text Block]	The carrying amount and fair value of the Company’s long-term gross borrowings were as follows: (in thousands) July 31, 2021 January 30, 2021 Gross borrowings outstanding, carrying amount $ 307,730 $ 350,000 Gross borrowings outstanding, fair value $ 340,811 $ 389,813

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	6 Months Ended
	Jul. 31, 2021
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	Property and equipment, net consisted of: (in thousands) July 31, 2021 January 30, 2021 Property and equipment, at cost $ 2,485,623 $ 2,488,957 Less: Accumulated depreciation and amortization (1,952,828) (1,938,370) Property and equipment, net $ 532,795 $ 550,587

Leases (Tables)

Leases (Tables)	6 Months Ended
	Jul. 31, 2021
Leases [Abstract]
Lease, Cost [Table Text Block]	The following table provides a summary of the Company’s operating lease costs for the thirteen and twenty-six weeks ended July 31, 2021 and August 1, 2020: Thirteen Weeks Ended Twenty-six Weeks Ended (in thousands) July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 Single lease cost (1) $ 70,325 $ 87,698 $ 140,077 $ 181,189 Variable lease cost (2) 19,300 19,433 42,466 47,335 Operating lease right-of-use asset impairment (3) 240 5,410 2,704 40,418 Sublease income (4) (1,095) — (2,188) — Total operating lease cost $ 88,770 $ 112,541 $ 183,059 $ 268,942 (1) Included amortization and interest expense associated with operating lease right-of-use assets and the impact from remeasurement of operating lease liabilities. (2) Included variable payments related to both lease and nonlease components, such as contingent rent payments made by the Company based on performance, and payments related to taxes, insurance, and maintenance costs, as well as the benefit of $5.2 million and $13.0 million of rent abatements during the thirteen and twenty-six weeks ended July 31, 2021 related to the effects of the COVID-19 pandemic that resulted in the total payments required by the modified contract being substantially the same as or less than total payments required by the original contract. Rent abatements obtained during the thirteen and twenty-six weeks ended August 1, 2020 were not significant. (3) Refer to Note 9, “ ASSET IMPAIRMENT ,” for details related to operating lease right-of-use asset impairment charges. (4) The terms of the sublease agreement entered into by the Company with a third party during Fiscal 2020 related to one of its previous flagship store locations have not changed materially from that disclosed in Note 8, “LEASES,” of the Notes to Consolidated Financial Statements contained in “ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA” of A&F’s Annual Report on Form 10-K for Fiscal 2020. Sublease income is recognized in other operating income (loss), net on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).

Asset Impairment (Tables)

Asset Impairment (Tables)	6 Months Ended
	Jul. 31, 2021
Asset Impairment [Abstract]
Asset Impairment Charges [Text Block]	Asset impairment charges for the thirteen and twenty-six weeks ended July 31, 2021 and August 1, 2020 were as follows: Thirteen Weeks Ended Twenty-six Weeks Ended (in thousands) July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 Operating lease right-of-use asset impairment $ 240 $ 5,410 $ 2,704 $ 40,418 Property and equipment asset impairment 546 2,673 746 10,593 Total asset impairment $ 786 $ 8,083 $ 3,450 $ 51,011

Borrowings (Tables)

Borrowings (Tables)	6 Months Ended
	Jul. 31, 2021
Debt Disclosure [Abstract]
Schedule of Borrowings	Details on the Company’s long-term borrowings, net, as of July 31, 2021 and January 30, 2021 are as follows: (in thousands) July 31, 2021 January 30, 2021 Long-term portion of borrowings, gross at carrying amount $ 307,730 $ 350,000 Unamortized fees (4,715) (6,090) Long-term borrowings, net $ 303,015 $ 343,910

Share-Based Compensation (Table

Share-Based Compensation (Tables)	6 Months Ended
	Jul. 31, 2021
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]	The following table details share-based compensation expense and the related income tax impacts for the thirteen and twenty-six weeks ended July 31, 2021 and August 1, 2020: Thirteen Weeks Ended Twenty-six Weeks Ended (in thousands) July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 Share-based compensation expense $ 6,487 $ 3,744 $ 14,937 $ 8,906 Income tax benefit associated with share-based compensation expense recognized (1) $ 1,388 $ — $ 1,686 $ — (1) No income tax benefit was recognized during the thirteen and twenty-six weeks ended August 1, 2020 due to the establishment of a valuation allowance.
Share-based Payment Arrangement, Discrete Tax Benefit (Charge) [Table Text Block]	The following table details discrete income tax benefits and charges related to share-based compensation awards during the thirteen and twenty-six weeks ended July 31, 2021 and August 1, 2020: Thirteen Weeks Ended Twenty-six Weeks Ended (in thousands) July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 Income tax discrete benefits realized for tax deductions related to the issuance of shares (1) $ 826 $ — $ 4,016 $ — Income tax discrete charges realized upon cancellation of stock appreciation rights (1) — — (3) — Total income tax discrete benefits related to share-based compensation awards (1) $ 826 $ — $ 4,013 $ — (1) No income tax benefit was recognized during the thirteen and twenty-six weeks ended August 1, 2020 due to the establishment of a valuation allowance.
Schedule of Restricted Stock Unit Activity	The following table summarizes activity for restricted stock units for the twenty-six weeks ended July 31, 2021: Service-based Restricted Performance-based Restricted Market-based Restricted Number of Weighted- Number of Weighted- Number of Weighted- Unvested at January 30, 2021 3,037,098 $ 11.62 297,216 $ 22.43 721,879 $ 21.46 Granted 659,612 32.38 146,580 31.78 73,294 49.81 Adjustments for performance achievement — — (106,715) 21.31 (6,084) 33.69 Vested (1,019,420) 12.19 — — (100,634) 33.69 Forfeited (45,199) 12.73 (1,704) 23.05 (10,657) 17.84 Unvested at July 31, 2021 (1) 2,632,091 $ 16.58 335,377 $ 26.87 677,798 $ 22.66 (1) Unvested shares related to restricted stock units with performance-based and market-based vesting conditions are reflected at 100% of their target vesting amount in the table above. Unvested shares related to restricted stock units with performance-based and market-based vesting conditions can be achieved at up to 200% of their target vesting amount.
Schedule of Stock Appreciation Rights Activity	The following table summarizes stock appreciation rights activity for the twenty-six weeks ended July 31, 2021: Number of Weighted-Average Aggregate Weighted-Average Outstanding at January 30, 2021 384,757 $ 33.04 Granted — — Exercised (107,068) 26.89 Forfeited or expired (34,150) 54.87 Outstanding at July 31, 2021 243,539 $ 32.69 $ 2,029,216 2.8 Stock appreciation rights exercisable at July 31, 2021 243,539 $ 32.69 $ 2,029,216 2.8 Stock appreciation rights expected to become exercisable in the future as of July 31, 2021 — $ — $ — 0.0 No stock appreciation rights were exercised during the twenty-six weeks ended August 1, 2020. Information pertaining to stock appreciation rights exercised during the twenty-six weeks ended July 31, 2021 follows: (in thousands) July 31, 2021 Total grant date fair value of awards exercised $ 1,020
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award	The following table details unrecognized compensation cost and the remaining weighted-average period over which these costs are expected to be recognized for restricted stock units as of July 31, 2021: (in thousands) Service-based Restricted Performance-based Restricted Market-based Restricted Unrecognized compensation cost $ 36,486 $ 5,076 $ 9,330 Remaining weighted-average period cost is expected to be recognized (years) 1.3 1.2 1.0
Employee tax withheld by company for share-based compensation	The following table details the amount of employee tax withheld by the Company upon the issuance of shares associated with restricted stock units vesting and the exercise of stock appreciation rights for the thirteen and twenty-six weeks ended July 31, 2021 and August 1, 2020: Thirteen Weeks Ended Twenty-six Weeks Ended (in thousands) July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 Employee tax withheld upon issuance of shares (1) $ 312 $ 93 $ 12,060 $ 5,416 (1) Classified within other financing activities on the Condensed Consolidated Statements of Cash Flows.
Market-based restricted stock units [Member]
Schedule of Weighted-Average Estimated Fair Value and Assumptions of Restricted Stock Units with Market Vesting Conditions	Additional information pertaining to restricted stock units for the twenty-six weeks ended July 31, 2021 and August 1, 2020 follows: (in thousands) July 31, 2021 August 1, 2020 Service-based restricted stock units: Total grant date fair value of awards granted $ 21,358 $ 13,752 Total grant date fair value of awards vested $ 12,427 $ 12,834 Performance-based restricted stock units: Total grant date fair value of awards granted $ 4,658 $ — Total grant date fair value of awards vested $ — $ 4,635 Market-based restricted stock units: Total grant date fair value of awards granted $ 3,651 $ — Total grant date fair value of awards vested $ 3,390 $ 4,132 No market-based restricted stock units were granted during the twenty-six weeks ended August 1, 2020. The weighted-average assumptions used for market-based restricted stock units in the Monte Carlo simulation during the twenty-six weeks ended July 31, 2021 were as follows: July 31, 2021 Grant date market price $ 31.78 Fair value $ 49.81 Assumptions: Price volatility 66 % Expected term (years) 2.9 Risk-free interest rate 0.3 % Dividend yield — % Average volatility of peer companies 72.0 % Average correlation coefficient of peer companies 0.4694

Derivative Instruments (Tables)

Derivative Instruments (Tables)	6 Months Ended
	Jul. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Outstanding Foreign Exchange Forward Contracts	As of July 31, 2021, the Company had outstanding the following foreign currency exchange forward contracts that were entered into to hedge either a portion, or all, of forecasted foreign-currency-denominated intercompany inventory sales, the resulting settlement of the foreign-currency-denominated intercompany accounts receivable, or both: (in thousands) Notional Amount (1) Euro $ 123,157 British pound $ 82,236 Canadian dollar $ 18,181 Japanese yen $ 7,120 (1) Amount reported is the U.S. Dollar notional amount outstanding as of July 31, 2021.
Location and Amounts of Derivative Fair Values on the Condensed Consolidated Balance Sheets	The fair value of derivative instruments is valued using quoted market prices of the same or similar instruments, adjusted for counterparty risk. The location and amounts of derivative fair values of foreign currency exchange forward contracts on the Condensed Consolidated Balance Sheets as of July 31, 2021 and January 30, 2021 were as follows: (in thousands) Location July 31, 2021 January 30, 2021 Location July 31, 2021 January 30, 2021 Derivatives designated as cash flow hedging instruments Other current assets $ 1,872 $ 79 Accrued expenses $ 794 $ 4,694 Derivatives not designated as hedging instruments Other current assets — — Accrued expenses — — Total $ 1,872 $ 79 $ 794 $ 4,694
Location and Amounts of Derivative Gains and Losses on the Condensed Consolidated Statements of Operations and Comprehensive Loss	Information pertaining to derivative gains or losses from foreign currency exchange forward contracts designated as cash flow hedging instruments for the thirteen and twenty-six weeks ended July 31, 2021 and August 1, 2020 follows: Thirteen Weeks Ended Twenty-six Weeks Ended (in thousands) July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 Gain recognized in AOCL (1) $ 1,084 $ — $ 2,228 $ 12,235 (Loss) gain reclassified from AOCL to cost of sales, exclusive of depreciation and amortization (2) $ (1,697) $ 2,407 $ (3,152) $ 5,777 (1) Amount represents the change in fair value of derivative contracts. As a result of COVID-19, there was a significant change in the expected timing of previously hedged intercompany sales transactions, resulting in a dedesignation of the related hedge instruments during the twenty-six weeks ended August 1, 2020. At the time of dedesignation of these hedges, they were in a net gain position of approximately $12.6 million. Due to the extenuating circumstances leading to dedesignation, gains associated with these hedges at the time of dedesignation were deferred in AOCL until being reclassified into cost of goods sold, exclusive of depreciation and amortization when the originally forecasted transactions occurred and the hedged items affected earnings. Subsequent to the dedesignation of these hedges, these hedge contracts were settled in Fiscal 2020. (2) Amount represents (loss) gain reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) when the hedged item affects earnings, which is when merchandise is converted to cost of sales, exclusive of depreciation and amortization. Substantially all of the unrealized gain will be recognized in costs of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) over the next twelve months. Additional information pertaining to derivative gains or losses from foreign currency exchange forward contracts not designated as hedging instruments for the thirteen and twenty-six weeks ended July 31, 2021 and August 1, 2020 follows: Thirteen Weeks Ended Twenty-six Weeks Ended (in thousands) July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 Gain (loss) recognized in other operating income, net $ 304 $ — $ (164) $ 742

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss (Tables)	6 Months Ended
	Jul. 31, 2021
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Loss	For the thirteen and twenty-six weeks ended July 31, 2021, the activity in AOCL was as follows: Thirteen Weeks Ended July 31, 2021 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at May 1, 2021 $ (99,046) $ (1,936) $ (100,982) Other comprehensive (loss) income before reclassifications (1,986) 1,084 (902) Reclassified loss from accumulated other comprehensive loss (1) — 1,697 1,697 Tax effect — (78) (78) Other comprehensive (loss) income after reclassifications (1,986) 2,703 717 Ending balance at July 31, 2021 $ (101,032) $ 767 $ (100,265) Twenty-six Weeks Ended July 31, 2021 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at January 30, 2021 $ (97,772) $ (4,535) $ (102,307) Other comprehensive (loss) income before reclassifications (3,260) 2,228 (1,032) Reclassified loss from accumulated other comprehensive loss (1) — 3,152 3,152 Tax effect — (78) (78) Other comprehensive income after reclassifications (3,260) 5,302 2,042 Ending balance at July 31, 2021 $ (101,032) $ 767 $ (100,265) (1) Amount represents loss reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss). For the thirteen and twenty-six weeks ended August 1, 2020, the activity in AOCL was as follows: Thirteen Weeks Ended August 1, 2020 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at May 2, 2020 $ (115,366) $ 9,946 $ (105,420) Other comprehensive income before reclassifications 8,734 — 8,734 Reclassified gain from accumulated other comprehensive loss (1) — (2,407) (2,407) Other comprehensive (loss) income after reclassifications (2) 8,734 (2,407) 6,327 Ending balance at August 1, 2020 $ (106,632) $ 7,539 $ (99,093) Twenty-six Weeks Ended August 1, 2020 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at February 1, 2020 $ (109,967) $ 1,081 $ (108,886) Other comprehensive income before reclassifications 3,335 12,235 15,570 Reclassified gain from accumulated other comprehensive loss (1) — (5,777) (5,777) Other comprehensive (loss) income after reclassifications (2) 3,335 6,458 9,793 Ending balance at August 1, 2020 $ (106,632) $ 7,539 $ (99,093) (1) Amount represents gain reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss). (2) No income tax benefit was recognized during the period due to the establishment of a valuation allowance.

Segment Reporting (Tables)

Segment Reporting (Tables)	6 Months Ended
	Jul. 31, 2021
Segment Reporting [Abstract]
Revenue from External Customers by Operating Segment [Table Text Block]	The Company’s net sales by operating segment for the thirteen and twenty-six weeks ended July 31, 2021 and August 1, 2020 were as follows: Thirteen Weeks Ended Twenty-six Weeks Ended (in thousands) July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 Hollister $ 514,483 $ 429,248 $ 956,891 $ 702,260 Abercrombie 350,367 269,080 689,364 481,427 Total $ 864,850 $ 698,328 $ 1,646,255 $ 1,183,687
Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country	The Company’s net sales by geographic area for the thirteen and twenty-six weeks ended July 31, 2021 and August 1, 2020 were as follows: Thirteen Weeks Ended Twenty-six Weeks Ended (in thousands) July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 U.S. $ 601,767 $ 458,671 $ 1,155,613 $ 781,533 EMEA 190,840 171,297 349,842 283,951 APAC 41,228 41,814 87,274 74,150 Other 31,015 26,546 53,526 44,053 International $ 263,083 $ 239,657 $ 490,642 $ 402,154 Total $ 864,850 $ 698,328 $ 1,646,255 $ 1,183,687

Flagship Store Exit (Benefits_2

Flagship Store Exit (Benefits) Charges (Tables)	6 Months Ended
	Jul. 31, 2021
Restructuring Cost and Reserve [Line Items]
Flagship Store Exit Charges [Table Text Block]	Details of the (benefits) charges recognized during the thirteen and twenty-six weeks ended July 31, 2021 and August 1, 2020 related to this initiative follow: Thirteen Weeks Ended Twenty-six Weeks Ended (in thousands) July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 Operating lease cost — (5,230) (841) (5,230) Asset disposals and other store-closure costs (1) — (3,205) (514) (3,205) Employee severance and other employee transition costs (88) 4,551 167 4,008 Total flagship store exit benefits $ (88) $ (3,884) $ (1,188) $ (4,427) (1) Amounts represent costs incurred or benefits realized associated with returning the store to its original condition, including updated estimates to previously established accruals for asset retirement obligations and costs to remove inventory and store assets.

Summary of Significant Accoun_6

Summary of Significant Accounting Policies Condensed Consolidated Statements of Cash Flows reconciliation (Details) - USD ($) $ in Thousands	Jul. 31, 2021	Jan. 30, 2021	Aug. 01, 2020	Feb. 01, 2020
Condensed Statements of Cash Flows reconciliation [Abstract]
Cash and equivalents	$ 921,504	$ 1,104,862	$ 766,721	$ 671,267
Restricted Cash and Cash Equivalents	14,268	14,814	19,269	18,696
Restricted Cash and Cash Equivalents, Current	267	4,481	0	2,301
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$ 936,039	$ 1,124,157	$ 785,990	$ 692,264

Summary of Significant Accoun_7

Summary of Significant Accounting Policies Recent Accounting Pronouncements (Details)	6 Months Ended
	Jul. 31, 2021
Recent Accounting Pronouncements [Abstract]
Maximum Length Of Time Inventory Sales Hedged	12 months

Summary of Significant Accoun_8

Summary of Significant Accounting Policies (Details) - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2021	Aug. 01, 2020	Jan. 30, 2021	Feb. 01, 2020
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net Cash Provided by (Used in) Operating Activities	$ 49,945	$ 46,233
Net Cash Provided by (Used in) Investing Activities	(35,269)	(25,621)
Net Cash Provided by (Used in) Financing Activities	(200,247)	71,329
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents		1,785
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	(188,118)	93,726
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$ 936,039	785,990	$ 1,124,157	$ 692,264
Scenario Originally Reported Member
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net Cash Provided by (Used in) Operating Activities		96,233
Net Cash Provided by (Used in) Investing Activities		(75,621)
Net Cash Provided by (Used in) Financing Activities		71,329
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents		1,785
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect		93,726
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents		785,990		$ 692,264
Restatement Adjustment Member
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net Cash Provided by (Used in) Operating Activities		(50,000)
Net Cash Provided by (Used in) Investing Activities		$ 50,000

Impact of COVID-19 (Details)

Impact of COVID-19 (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Aug. 01, 2020	Jul. 31, 2021	Aug. 01, 2020	Jan. 30, 2021
Impact of COVID-19 [Abstract]
Inventory Write-down		$ 14,800
Government Payroll Subsidies in response to COVID-19 Benefit	$ 500			$ 3,100
Asset Impairment Charges		8,100	$ 3,450	51,000
Asset impairment, exclusive of flagship store exit charges	786	$ 8,083	3,450	51,011
Income Tax Expense Benefit Continuing Operations Discrete Items				84,100
Proceeds from Short-term Debt			0	210,000
Withdrawal from Rabbi Trust Assets			0	50,000
RentAbatementsReceived			5,200
Proceeds from Notes Payable			0	$ 350,000
Accrued Rent, Current	$ 22,200		$ 22,200		$ 24,200

Revenue Recognition (Details)

Revenue Recognition (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Aug. 01, 2020	Jul. 31, 2021	Aug. 01, 2020	Jan. 30, 2021	Feb. 01, 2020
Revenue Recognition [Abstract]
Revenue recognized from Gift Card Program	$ 17,353	$ 10,066	$ 33,509	$ 21,075
Revenue recognized from Customer Loyalty Program Liability	9,897	7,982	19,450	13,691
Gift Card Liability, Current	29,038	22,461	29,038	22,461	$ 28,561	$ 28,844
Customer Loyalty Program Liability, Current	$ 20,962	$ 19,674	$ 20,962	$ 19,674	$ 20,426	$ 23,051

Net Income (Loss) Per Share (De

Net Income (Loss) Per Share (Details) - shares shares in Thousands		3 Months Ended		6 Months Ended
		Jul. 31, 2021	Aug. 01, 2020	Jul. 31, 2021	Aug. 01, 2020
Weighted Average Shares Outstanding And Anti Dilutive Shares [Abstract]
Shares of Common Stock issued		103,300	103,300	103,300	103,300
Weighted-average treasury shares		(41,872)	(40,773)	(41,386)	(40,757)
Weighted-average — basic shares		61,428	62,527	61,914	62,543
Dilutive effect of share-based compensation awards		2,708	759	2,889	0
Weighted-average — diluted shares		64,136	63,286	64,803	62,543
Anti-dilutive shares (1)	[1]	1,194	2,026	1,277	2,123
[1]	Reflects the total number of shares related to outstanding share-based compensation awards that have been excluded from the computation of net income (loss) per diluted share because the impact would have been anti-dilutive. Unvested shares related to restricted stock units with performance-based and market-based vesting conditions can achieve up to 200% of their target vesting amount and are reflected at the maximum vesting amount less any dilutive portion.

Fair Value (Assets and Liabilit

Fair Value (Assets and Liabilities at Fair Value) (Details) - USD ($) $ in Thousands	Jul. 31, 2021		Jan. 30, 2021
Fair Value, Recurring [Member]
Assets, Fair Value Disclosure [Abstract]
Cash and Cash Equivalents, Fair Value Disclosure	$ 177,899	[1]	$ 307,868
Derivative instruments (2)	1,872		79
Restricted Investments, Noncurrent	61,539		60,790
Restricted Cash Equivalents, Noncurrent	7,907		10,718
Total assets	249,217		379,455
Liabilities, Fair Value Disclosure [Abstract]
Derivative instruments (2)	794		4,694
Total liabilities	794		4,694
Level 1 | Fair Value, Recurring [Member]
Assets, Fair Value Disclosure [Abstract]
Cash and Cash Equivalents, Fair Value Disclosure	131,301	[1]	296,279
Derivative instruments (2)	0		0
Restricted Investments, Noncurrent	1		1
Restricted Cash Equivalents, Noncurrent	3,109		2,943
Total assets	134,411		299,223
Liabilities, Fair Value Disclosure [Abstract]
Derivative instruments (2)	0		0
Total liabilities	0		0
Level 2 | Fair Value, Recurring [Member]
Assets, Fair Value Disclosure [Abstract]
Cash and Cash Equivalents, Fair Value Disclosure	46,598	[1]	11,589
Derivative instruments (2)	1,872		79
Restricted Investments, Noncurrent	61,538		60,789
Restricted Cash Equivalents, Noncurrent	4,798		7,775
Total assets	114,806		80,232
Liabilities, Fair Value Disclosure [Abstract]
Derivative instruments (2)	794		4,694
Total liabilities	794		4,694
Level 3 | Fair Value, Recurring [Member]
Assets, Fair Value Disclosure [Abstract]
Cash and Cash Equivalents, Fair Value Disclosure	0	[1]	0
Derivative instruments (2)	0		0
Restricted Investments, Noncurrent	0		0
Restricted Cash Equivalents, Noncurrent	0		0
Total assets	0		0
Liabilities, Fair Value Disclosure [Abstract]
Derivative instruments (2)	0		0
Total liabilities	0		0
Term Loan Facility
Liabilities, Fair Value Disclosure [Abstract]
Gross borrowings outstanding, carrying amount	307,730		350,000
Gross borrowings outstanding, fair value			$ 389,813
Senior Notes [Member]
Liabilities, Fair Value Disclosure [Abstract]
Gross borrowings outstanding, fair value	$ 340,811
[1]	Level 1 assets consisted of investments in money market funds. Level 2 assets consisted of time deposits. (2) Level 2 assets and liabilities consisted primarily of foreign currency exchange forward contracts.

Property and Equipment, Net (De

Property and Equipment, Net (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Aug. 01, 2020	Jul. 31, 2021	Aug. 01, 2020	Jan. 30, 2021
Property, Plant and Equipment [Line Items]
Store asset impairment	$ 546	$ 2,673	$ 746	$ 10,593
Property and equipment, at cost	2,485,623		2,485,623		$ 2,488,957
Less: Accumulated depreciation and amortization	(1,952,828)		(1,952,828)		(1,938,370)
Property and equipment, net	532,795		532,795		$ 550,587
Asset Impairment Charges		8,100	3,450	51,000
Asset impairment, exclusive of flagship store exit charges	$ 786	$ 8,083	$ 3,450	$ 51,011

Leases (Details)

Leases (Details) - USD ($) $ in Thousands		3 Months Ended				6 Months Ended
		Jul. 31, 2021		Aug. 01, 2020		Jul. 31, 2021		Aug. 01, 2020
Leases [Abstract]
Single lease cost	[1]	$ 70,325		$ 87,698		$ 140,077		$ 181,189
Variable lease cost		19,300	[2]	19,433	[2]	42,466	[2]	47,335
Operating lease right-of-use asset impairment	[3]	240		5,410		2,704		40,418
Sublease Income	[4]	(1,095)		0
Operating lease cost		88,770		$ 112,541		183,059		268,942
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability						17,159		23,119
Cash paid for operating lease liabilities						230,836		$ 122,128
LesseeOperatingLeaseLeasesNotYetCommencedLiability		2,500				2,500
Rent Abatement Benefit to Variable Lease Cost		$ 5,200				$ 13,000
[1]	Included amortization and interest expense associated with operating lease right-of-use assets and the impact from remeasurement of operating lease liabilities.
[2]	Included variable payments related to both lease and nonlease components, such as contingent rent payments made by the Company based on performance, and payments related to taxes, insurance, and maintenance costs, as well as the benefit of $5.2 million and $13.0 million of rent abatements during the thirteen and twenty-six weeks ended July 31, 2021 related to the effects of the COVID-19 pandemic that resulted in the total payments required by the modified contract being substantially the same as or less than total payments required by the original contract. Rent abatements obtained during the thirteen and twenty-six weeks ended August 1, 2020 were not significant.
[3]	Refer to Note 9, “ ASSET IMPAIRMENT ,” for details related to operating lease right-of-use asset impairment charges. (4) The terms of the sublease agreement entered into by the Company with a third party during Fiscal 2020 related to one of its previous flagship store locations have not changed materially from that disclosed in Note 8, “LEASES,” of the Notes to Consolidated Financial Statements contained in “ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA” of A&F’s Annual Report on Form 10-K for Fiscal 2020. Sublease income is recognized in other operating income (loss), net on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).
[4]	The terms of the sublease agreement entered into by the Company with a third party during Fiscal 2020 related to one of its previous flagship store locations have not changed materially from that disclosed in Note 8, “LEASES,” of the Notes to Consolidated Financial Statements contained in “ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA” of A&F’s Annual Report on Form 10-K for Fiscal 2020. Sublease income is recognized in other operating income (loss), net on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).

Asset Impairment (Details)

Asset Impairment (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Aug. 01, 2020	Jul. 31, 2021	Aug. 01, 2020	Jan. 30, 2021
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Operating Lease, Right-of-Use Asset	$ 791,036		$ 791,036		$ 893,989
Asset impairment, exclusive of flagship store exit charges	786	$ 8,083	3,450	$ 51,011
Fair Value, Recurring [Member]
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Store Assets, including property and equipment and operating lease right-of-use assets	9,400	135,500	9,400	135,500
Operating Lease, Right-of-Use Asset	$ 8,800	$ 124,600	$ 8,800	$ 124,600

Rabbi Trust Assets (Details)

Rabbi Trust Assets (Details) - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2021	Aug. 01, 2020	Jan. 30, 2021
Defined Benefit Plan, Plan Assets, Category [Line Items]
Withdrawal from Rabbi Trust Assets	$ 0	$ 50,000
Fair Value, Recurring [Member]
Defined Benefit Plan, Plan Assets, Category [Line Items]
Restricted Investments, Noncurrent	61,539		$ 60,790
Fair Value, Recurring [Member] | Level 2
Defined Benefit Plan, Plan Assets, Category [Line Items]
Restricted Investments, Noncurrent	61,538		60,789
Fair Value, Recurring [Member] | Level 1
Defined Benefit Plan, Plan Assets, Category [Line Items]
Restricted Investments, Noncurrent	$ 1		$ 1

Income Taxes (Details)

Income Taxes (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Aug. 01, 2020	Jul. 31, 2021	Aug. 01, 2020
Valuation Allowance [Line Items]
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	$ (6,700,000)		$ (10,100,000)	$ (36,500,000)
Unrecognized Tax Benefits that Would Impact Effective Tax Rate		$ 47,600,000		47,600,000
Income Tax Expense Benefit Continuing Operations Discrete Items				84,100,000
Valuation Allowance, Deferred Tax Asset, Discrete Benefit, Increase (Decrease) Amount	23,500,000		23,600,000
Income Tax Expense Benefit Continuing Operations Discrete Items				84,100,000
Pre-Tax Losses Without Tax Benefits Recognized				204,100,000
Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability	3,900,000		3,900,000
Income Tax Expense (Benefit)	$ (6,944,000)	$ 1,253,000	$ (823,000)	32,786,000
United States
Valuation Allowance [Line Items]
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount				(10,600,000)
GERMANY
Valuation Allowance [Line Items]
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount				(6,000,000)
SWITZERLAND
Valuation Allowance [Line Items]
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount				$ (78,900,000)

Borrowings (Details)

Borrowings (Details) - USD ($)	3 Months Ended	6 Months Ended
	Jul. 31, 2021	Jul. 31, 2021	Aug. 01, 2020	Jan. 30, 2021
Long-Term Borrowings [Line Items]
Debt Instrument, Repurchased Face Amount	$ 42,300,000	$ 42,300,000
Debt Instrument, Unamortized Premium	4,700,000	4,700,000
Loss on extinguishment of debt	$ 5,300,000	$ (5,347,000)	$ 0
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate	8.75%	8.75%
Line of Credit Facility, Remaining Borrowing Capacity	$ 278,600,000	$ 278,600,000
Deferred financing fees	600,000	600,000
Long-term Debt, Excluding Current Maturities	303,015,000	303,015,000		$ 343,910,000
Schedule of Future Payments of the Term Loan Facility
ABL Facility, covenant terms, minimum remaining borrowing capacity	248,600,000	248,600,000
Letters of Credit Outstanding, Amount	(800,000)	(800,000)
Repayments of Short-term Debt		0	$ 210,000,000
Senior Notes	350,000,000	350,000,000
Senior Notes [Member]
Long-Term Borrowings [Line Items]
Unamortized discount	(4,715,000)	(4,715,000)
Term Loan Facility
Long-Term Borrowings [Line Items]
Gross borrowings outstanding, carrying amount	307,730,000	307,730,000		350,000,000
Unamortized Debt Issuance Expense Fees Paid to Lenders				(6,090,000)
Borrowings, net				$ 343,910,000
ABL Facility
Long-Term Borrowings [Line Items]
Maximum borrowing capacity	$ 400,000,000	$ 400,000,000
Maturity date		Apr. 29, 2026

Borrowings Schedule of Short-te

Borrowings Schedule of Short-term borrowings (Details) $ in Millions	Jul. 31, 2021USD ($)
Short-term debt disclosure [Abstract]
Line of Credit Facility, Remaining Borrowing Capacity	$ 278.6

Share-Based Compensation (Detai

Share-Based Compensation (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended
	Jul. 31, 2021	Aug. 01, 2020		Jul. 31, 2021	Aug. 01, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	$ (312)	$ (93)		$ (12,060)	$ (5,416)
Payment, Tax Withholding, Share-based Payment Arrangement	312	93		12,060	5,416
Share-based compensation expense	6,487	3,744		14,937	8,906
Tax benefit recognized related to share-based compensation expense	1,388	0	[1]	1,686	0
Share-based Payment Arrangement, Exercise of Option, Tax Benefit	826	0	[2]	4,016	0
Total grant date fair value of awards vested				1,020
Share-based Payment Arrangement, Cancellation of Option, Tax Charge	0	0	[2]	(3)	0
Share-based Payment Arrangement, Discrete Income Tax Benefit (Charge)	826	0		4,013	0
Service-based restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost, net of estimated forfeitures	36,486			$ 36,486
Unrecognized compensation cost, weighted-average period of recognition				1 year 3 months 18 days
Total grant date fair value of awards granted				$ 21,358	13,752
Total grant date fair value of awards vested				12,427	12,834
Performance-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost, net of estimated forfeitures	5,076			$ 5,076
Unrecognized compensation cost, weighted-average period of recognition				1 year 2 months 12 days
Total grant date fair value of awards granted				$ 4,658	0
Total grant date fair value of awards vested				0	4,635
Market-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost, net of estimated forfeitures	9,330			$ 9,330
Unrecognized compensation cost, weighted-average period of recognition				1 year
Total grant date fair value of awards granted				$ 3,651	0
Total grant date fair value of awards vested				3,390	4,132
Additional Paid-in Capital [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	(1,873)	(1,376)		(16,329)	(21,617)
Share-based compensation expense	$ 6,487	$ 3,744		$ 14,937	$ 8,906
[1]	No income tax benefit was recognized during the thirteen and twenty-six weeks ended August 1, 2020 due to the establishment of a valuation allowance.
[2]	No income tax benefit was recognized during the thirteen and twenty-six weeks ended August 1, 2020 due to the establishment of a valuation allowance.

Share-Based Compensation (Restr

Share-Based Compensation (Restricted Stock Units Activity) (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended			6 Months Ended
		Jul. 31, 2021	Aug. 01, 2020	[1]	Jul. 31, 2021	Aug. 01, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Exercise of Option, Tax Benefit		$ 826	$ 0		$ 4,016	$ 0
Restricted Stock Unit Activity, Number of Underlying Shares
Number of Underlying Shares, Beginning Balance at January 30, 2021					384,757
Number of Underlying Shares, Granted					0
Number of Underlying Shares, Forfeited					(34,150)
Number of Underlying Shares, Ending Balance at July 31, 2021		243,539			243,539
Restricted Stock Unit Activity, Weighted-Average Grant Date Fair Value
Weighted-Average Grant Date Fair Value, Beginning Balance at January 30, 2021					$ 33.04
Weighted-Average Grant Date Fair Value, Granted					0
Weighted-Average Grant Date Fair Value, Forfeited					54.87
Weighted-Average Grant Date Fair Value, Ending Balance at July 31, 2021		$ 32.69			$ 32.69
Service-based restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount		$ 36,486			$ 36,486
Restricted Stock Unit Activity, Number of Underlying Shares
Number of Underlying Shares, Beginning Balance at January 30, 2021					3,037,098
Number of Underlying Shares, Granted					659,612
Number of Underlying Shares, Adjustments for performance achievement					0
Number of Underlying Shares, Vested					(1,019,420)
Number of Underlying Shares, Forfeited					(45,199)
Number of Underlying Shares, Ending Balance at July 31, 2021	[2]	2,632,091			2,632,091
Restricted Stock Unit Activity, Weighted-Average Grant Date Fair Value
Weighted-Average Grant Date Fair Value, Beginning Balance at January 30, 2021					$ 11.62
Weighted-Average Grant Date Fair Value, Granted					32.38
Weighted-Average Grant Date Fair Value, Adjustments for performance achievement					0
Weighted-Average Grant Date Fair Value, Vested					12.19
Weighted-Average Grant Date Fair Value, Forfeited					12.73
Weighted-Average Grant Date Fair Value, Ending Balance at July 31, 2021		$ 16.58			$ 16.58
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition					1 year 3 months 18 days
Performance-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount		$ 5,076			$ 5,076
Restricted Stock Unit Activity, Number of Underlying Shares
Number of Underlying Shares, Beginning Balance at January 30, 2021					297,216
Number of Underlying Shares, Granted					146,580
Number of Underlying Shares, Adjustments for performance achievement					(106,715)
Number of Underlying Shares, Vested					0
Number of Underlying Shares, Forfeited					(1,704)
Number of Underlying Shares, Ending Balance at July 31, 2021		335,377			335,377
Restricted Stock Unit Activity, Weighted-Average Grant Date Fair Value
Weighted-Average Grant Date Fair Value, Beginning Balance at January 30, 2021					$ 22.43
Weighted-Average Grant Date Fair Value, Granted					31.78
Weighted-Average Grant Date Fair Value, Adjustments for performance achievement					21.31
Weighted-Average Grant Date Fair Value, Vested					0
Weighted-Average Grant Date Fair Value, Forfeited					23.05
Weighted-Average Grant Date Fair Value, Ending Balance at July 31, 2021		$ 26.87			$ 26.87
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition					1 year 2 months 12 days
Market-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount		$ 9,330			$ 9,330
Restricted Stock Unit Activity, Number of Underlying Shares
Number of Underlying Shares, Beginning Balance at January 30, 2021					721,879
Number of Underlying Shares, Granted					73,294
Number of Underlying Shares, Adjustments for performance achievement					(6,084)
Number of Underlying Shares, Vested					(100,634)
Number of Underlying Shares, Forfeited					(10,657)
Number of Underlying Shares, Ending Balance at July 31, 2021		677,798			677,798
Restricted Stock Unit Activity, Weighted-Average Grant Date Fair Value
Weighted-Average Grant Date Fair Value, Beginning Balance at January 30, 2021					$ 21.46
Weighted-Average Grant Date Fair Value, Granted					49.81
Weighted-Average Grant Date Fair Value, Adjustments for performance achievement					33.69
Weighted-Average Grant Date Fair Value, Vested					33.69
Weighted-Average Grant Date Fair Value, Forfeited					17.84
Weighted-Average Grant Date Fair Value, Ending Balance at July 31, 2021		$ 22.66			$ 22.66
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition					1 year
[1]	No income tax benefit was recognized during the thirteen and twenty-six weeks ended August 1, 2020 due to the establishment of a valuation allowance.
[2]	Unvested shares related to restricted stock units with performance-based and market-based vesting conditions are reflected at 100% of their target vesting amount in the table above. Unvested shares related to restricted stock units with performance-based and market-based vesting conditions can be achieved at up to 200% of their target vesting amount.

Share-Based Compensation (Res_2

Share-Based Compensation (Restricted Stock Units Assumptions) (Details)	6 Months Ended
	Jul. 31, 2021$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Document Period End Date	Jul. 31, 2021
Fair value (in dollars per share)	$ 0
City Area Code	(614)
Market-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant date market price (in dollars per share)	$ 31.78
Fair value (in dollars per share)	$ 49.81
Price volatility	66.00%
Expected term (years)	2 years 10 months 24 days
Risk-free interest rate	0.30%
Dividend yield	0.00%
Average volatility of peer companies	72.00%
Average correlation coefficient of peer companies	0.4694

Share-Based Compensation (Stock

Share-Based Compensation (Stock Appreciation Rights Activity) (Details)	6 Months Ended
	Jul. 31, 2021USD ($)$ / sharesshares
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value | $	$ 1,020,000
Stock Appreciation Rights Activity, Number of Underlying Shares
Number of Underlying Shares, Beginning Balance at January 30, 2021 | shares	384,757
Number of Underlying Shares, Granted | shares	0
Number of Underlying Shares, Exercised | shares	(107,068)
Number of Underlying Shares, Forfeited | shares	(34,150)
Number of Underlying Shares, Ending Balance at July 31, 2021 | shares	243,539
Number of Underlying shares, Stock appreciation rights exercisable | shares	243,539
Number of Underlying Shares, Stock appreciation rights expected to become exercisable | shares	0
Stock Appreciation Rights, Weighted-Average Exercise Price
Weighted-Average Grant Date Fair Value, Beginning Balance at January 30, 2021 | $ / shares	$ 33.04
Weighted-Average Exercise Price, Granted | $ / shares	0
Weighted-Average Exercise Price, Exercised | $ / shares	26.89
Weighted-Average Exercise Price, Forfeited or expired | $ / shares	54.87
Weighted-Average Grant Date Fair Value, Ending Balance at July 31, 2021 | $ / shares	32.69
Weighted-Average Exercise Price, Stock appreciation rights exercisable | $ / shares	32.69
Weighted-Average Exercise Price, Stock appreciation rights expected to become exercisable | $ / shares	$ 0
Aggregate Intrinsic Value, Outstanding | $	$ 2,029,216
Aggregate Intrinsic Value, Stock appreciation rights exercisable | $	2,029,216
Aggregate Intrinsic Value, Stock appreciation rights expected to become exercisable | $	$ 0
Weighted-Average Remaining Contractual Life, Outstanding	2 years 9 months 18 days
Weighted-Average Remaining Contractual Life, Stock appreciation rights exercisable	2 years 9 months 18 days
Weighted Average Remaining Contractual Life, Stock appreciation rights expected to become exercisable	0 years

Derivative Instruments (Outstan

Derivative Instruments (Outstanding Foreign Exchange Forward Contracts) (Details) $ in Thousands	Jul. 31, 2021USD ($)	[1]
Euro Member Countries, Euro
Derivative [Line Items]
Notional Amount	$ 123,157
United Kingdom, Pounds
Derivative [Line Items]
Notional Amount	82,236
Canada, Dollars
Derivative [Line Items]
Notional Amount	18,181
Japan, Yen
Derivative [Line Items]
Notional Amount	$ 7,120
[1]	Amount reported is the U.S. Dollar notional amount outstanding as of July 31, 2021.

Derivative Instruments (Derivat

Derivative Instruments (Derivative Fair Values on the Condensed Consolidated Balance Sheets) (Details) - USD ($) $ in Thousands	Jul. 31, 2021	Jan. 30, 2021
Derivative Instruments, Gain (Loss) [Line Items]
Foreign Currency Cash Flow Hedge Asset at Fair Value	$ 1,872	$ 79
Foreign Currency Cash Flow Hedge Liability at Fair Value	794	4,694
Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Asset at Fair Value	0	0
Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Liability at Fair Value	0	0
Fair Value, Recurring [Member]
The location and amounts of derivative fair values on the Condensed Consolidated Balance Sheets
Other current assets	1,872	79
Accrued expenses	794	4,694
Level 2 | Fair Value, Recurring [Member]
The location and amounts of derivative fair values on the Condensed Consolidated Balance Sheets
Other current assets	1,872	79
Accrued expenses	$ 794	$ 4,694

Derivative Instruments (Deriv_2

Derivative Instruments (Derivative Gains (Losses) on the Condensed Consolidated Statement of Operations) (Details) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jul. 31, 2021	Aug. 01, 2020	Jul. 31, 2021	Aug. 01, 2020
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in AOCL on Derivative Contracts (Effective Portion)	[1]	$ 1,084	$ 0	$ 2,228	$ 12,235
Amount of Gain (Loss) Reclassified from AOCL into Earnings (Effective Portion)	[2]	(1,697)	2,407	(3,152)	5,777
Gain/(Loss)		$ 304	$ 0	$ (164)	$ 742
[1]	Amount represents the change in fair value of derivative contracts. As a result of COVID-19, there was a significant change in the expected timing of previously hedged intercompany sales transactions, resulting in a dedesignation of the related hedge instruments during the twenty-six weeks ended August 1, 2020. At the time of dedesignation of these hedges, they were in a net gain position of approximately $12.6 million. Due to the extenuating circumstances leading to dedesignation, gains associated with these hedges at the time of dedesignation were deferred in AOCL until being reclassified into cost of goods sold, exclusive of depreciation and amortization when the originally forecasted transactions occurred and the hedged items affected earnings. Subsequent to the dedesignation of these hedges, these hedge contracts were settled in Fiscal 2020.
[2]	Amount represents (loss) gain reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) when the hedged item affects earnings, which is when merchandise is converted to cost of sales, exclusive of depreciation and amortization.

Derivative Instruments (Details

Derivative Instruments (Details) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jul. 31, 2021	Aug. 01, 2020	Jul. 31, 2021	Aug. 01, 2020	Jan. 30, 2021
Derivative Instruments, Gain (Loss) [Line Items]
Derivatives, Gain Deferred in AOCL				$ 12,600
Foreign Currency Cash Flow Hedge Asset at Fair Value		$ 1,872		1,872		$ 79
Foreign Currency Cash Flow Hedge Liability at Fair Value		794		794		4,694
Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Asset at Fair Value		0		0		0
Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Liability at Fair Value		0		0		0
Derivative Instruments, Gain (Loss) Reclassified from Accumulated AOCL into Income, Effective Portion, Net	[1]	(1,697)	$ 2,407	$ (3,152)	$ 5,777
Length of time inventory sales hedged (in months)				12 months
Derivative Instruments, Gain (Loss) Recognized in AOCL, Effective Portion, Net	[2]	1,084	$ 0	$ 2,228	$ 12,235
Euro Member Countries, Euro
Derivative Instruments, Gain (Loss) [Line Items]
Notional Amount	[3]	123,157		123,157
United Kingdom, Pounds
Derivative Instruments, Gain (Loss) [Line Items]
Notional Amount	[3]	82,236		82,236
Canada, Dollars
Derivative Instruments, Gain (Loss) [Line Items]
Notional Amount	[3]	18,181		18,181
Japan, Yen
Derivative Instruments, Gain (Loss) [Line Items]
Notional Amount	[3]	7,120		7,120
Fair Value, Recurring [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other current assets		1,872		1,872		79
Accrued expenses		794		794		4,694
Level 2 | Fair Value, Recurring [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other current assets		1,872		1,872		79
Accrued expenses		$ 794		$ 794		$ 4,694
[1]	Amount represents (loss) gain reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) when the hedged item affects earnings, which is when merchandise is converted to cost of sales, exclusive of depreciation and amortization.
[2]	Amount represents the change in fair value of derivative contracts. As a result of COVID-19, there was a significant change in the expected timing of previously hedged intercompany sales transactions, resulting in a dedesignation of the related hedge instruments during the twenty-six weeks ended August 1, 2020. At the time of dedesignation of these hedges, they were in a net gain position of approximately $12.6 million. Due to the extenuating circumstances leading to dedesignation, gains associated with these hedges at the time of dedesignation were deferred in AOCL until being reclassified into cost of goods sold, exclusive of depreciation and amortization when the originally forecasted transactions occurred and the hedged items affected earnings. Subsequent to the dedesignation of these hedges, these hedge contracts were settled in Fiscal 2020.
[3]	Amount reported is the U.S. Dollar notional amount outstanding as of July 31, 2021.

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss (Details) - USD ($)	3 Months Ended				6 Months Ended
	Jul. 31, 2021		Aug. 01, 2020		Jul. 31, 2021		Aug. 01, 2020
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance	$ (100,982,000)		$ (105,420,000)		$ (102,307,000)		$ (108,886,000)
Other comprehensive (loss) income before reclassifications	(902,000)		8,734,000		(1,032,000)		15,570,000
Reclassified loss from accumulated other comprehensive loss (1)	1,697,000	[1]	(2,407,000)	[2]	3,152,000	[1]	(5,777,000)	[2]
Tax effect	78,000				78,000
Other comprehensive income after reclassifications	717,000		6,327,000	[3]	2,042,000		9,793,000
Ending balance at July 31, 2021	(100,265,000)		(99,093,000)		(100,265,000)		(99,093,000)
Foreign Currency Translation Adjustment
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance	(99,046,000)		(115,366,000)		(97,772,000)		(109,967,000)
Other comprehensive (loss) income before reclassifications	(1,986,000)		8,734,000		(3,260,000)		3,335,000
Reclassified loss from accumulated other comprehensive loss (1)	0		0		0		0
Tax effect	0				0
Other comprehensive income after reclassifications	(1,986,000)		8,734,000	[3]	(3,260,000)		3,335,000
Ending balance at July 31, 2021	(101,032,000)		(106,632,000)		(101,032,000)		(106,632,000)
Unrealized Gain (Loss) on Derivative Financial Instruments
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance	(1,936,000)		9,946,000		(4,535,000)		1,081,000
Other comprehensive (loss) income before reclassifications	1,084,000		0		2,228,000		12,235,000
Reclassified loss from accumulated other comprehensive loss (1)	1,697,000	[1]	(2,407,000)	[2]	3,152,000		(5,777,000)
Tax effect	78,000				78,000
Other comprehensive income after reclassifications	2,703,000		(2,407,000)	[3]	5,302,000		6,458,000
Ending balance at July 31, 2021	$ 767,000		$ 7,539,000		$ 767,000		$ 7,539,000
[1]	Amount represents loss reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).
[2]	Amount represents gain reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).
[3]	No income tax benefit was recognized during the period due to the establishment of a valuation allowance.

Segment Reporting (Segment Repo

Segment Reporting (Segment Reporting Information, by Segment) (Details)	3 Months Ended	6 Months Ended
	Jul. 31, 2021	Jul. 31, 2021
Segment Reporting Information [Line Items]
Number of Operating Segments	2
Number of reportable segments		1

Segment Reporting (Net Sales by

Segment Reporting (Net Sales by Brand) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Aug. 01, 2020	Jul. 31, 2021	Aug. 01, 2020
Schedule of Revenue by Brand [Line Items]
Net sales	$ 864,850	$ 698,328	$ 1,646,255	$ 1,183,687
Hollister
Schedule of Revenue by Brand [Line Items]
Net sales	514,483	429,248	956,891	702,260
Abercrombie
Schedule of Revenue by Brand [Line Items]
Net sales	$ 350,367	$ 269,080	$ 689,364	$ 481,427

Segment Reporting (Sales by Geo

Segment Reporting (Sales by Geographic Area) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Aug. 01, 2020	Jul. 31, 2021	Aug. 01, 2020
Net sales	$ 864,850	$ 698,328	$ 1,646,255	$ 1,183,687
United States
Net sales	601,767	458,671	1,155,613	781,533
EMEA [Member]
Net sales	190,840	171,297	349,842	283,951
Asia Pacific [Member]
Net sales	41,228	41,814	87,274	74,150
Other
Net sales	31,015	26,546	53,526	44,053
International [Member]
Net sales	$ 263,083	$ 239,657	$ 490,642	$ 402,154

Flagship Store Exit (Benefits_3

Flagship Store Exit (Benefits) Charges (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jul. 31, 2021		Aug. 01, 2020		Jul. 31, 2021	Aug. 01, 2020	Apr. 29, 2021
Flagship Store Exit Charges [Abstract]
Lease Cost from Flagship Store Exits	$ 0		$ (5,230)		$ (841)	$ (5,230)
Property, Plant and Equipment, Disposals	0	[1]	(3,205)	[1]	(514)	(3,205)
Severance Costs	(88)		4,551		167	4,008
Flagship store exit benefits	(88)		$ (3,884)		(1,188)	(4,427)
Cash paid for operating lease liabilities					230,836	122,128
Restructuring Cost and Reserve [Line Items]
Cash paid for operating lease liabilities					230,836	$ 122,128
SoHo New York City Flagship Store
Flagship Store Exit Charges [Abstract]
Gain (Loss) on Termination of Lease					900
Cash paid for operating lease liabilities					63,800
Reduction of Operating Lease Liability	65,000				65,000
Operating Lease, Liability							$ 80,100
Restructuring Cost and Reserve [Line Items]
Cash paid for operating lease liabilities					63,800
Reduction of Operating Lease Liability	$ 65,000				65,000
Operating Lease, Liability							$ 80,100
Gain (Loss) on Termination of Lease					$ 900
[1]	Amounts represent costs incurred or benefits realized associated with returning the store to its original condition, including updated estimates to previously established accruals for asset retirement obligations and costs to remove inventory and store assets